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ABSTRACT  
   
Cardiovascular disease (CVD) is the number one cause of death in the United States and 
type 2 diabetes (T2D) and obesity lead to cardiovascular disease. Obese adults are more 
susceptible to CVD compared to their non-obese counterparts. Exercise training leads to 
large reductions in the risk of CVD and T2D. Recent evidence suggests high-intensity 
interval training (HIT) may yield similar or superior benefits in a shorter amount of time 
compared to traditional continuous exercise training. The purpose of this study was to 
compare the effects of HIT to continuous (CONT) exercise training for the improvement 
of endothelial function, glucose control, and visceral adipose tissue. Seventeen obese men 
(N=9) and women (N=8) were randomized to eight weeks of either HIT (N=9, age=34 
years, BMI=37.6 kg/m2) or CONT (N=8, age=34 years, BMI=34.6 kg/m2) exercise 3 
days/week for 8 weeks. Endothelial function was assessed via flow-mediated dilation 
(FMD), glucose control was assessed via continuous glucose monitoring (CGM), and 
visceral adipose tissue and body composition was measured with an iDXA. Incremental 
exercise testing was performed at baseline, 4 weeks, and 8 weeks. There were no changes 
in weight, fat mass, or visceral adipose tissue measured by the iDXA, but there was a 
significant reduction in body fat that did not differ by group (46±6.3 to 45.4±6.6%, 
P=0.025). HIT led to a significantly greater improvement in FMD compared to CONT 
exercise (HIT: 5.1 to 9.0%; CONT: 5.0 to 2.6%, P=0.006). Average 24-hour glucose was 
not improved over the whole group and there were no group x time interactions for CGM 
data (HIT: 103.9 to 98.2 mg/dl; CONT: 99.9 to 100.2 mg/dl, P>0.05). When statistical 
analysis included only the subjects who started with an average glucose at baseline > 100 
mg/dl, there was a significant improvement in glucose control overall, but no group x 
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time interaction (107.8 to 94.2 mg/dl, P=0.027). Eight weeks of HIT led to superior 
improvements in endothelial function and similar improvements in glucose control in 
obese subjects at risk for T2D and CVD. HIT was shown to have comparable or superior 
health benefits in this obese sample with a 36% lower total exercise time commitment.
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Chapter 1 
INTRODUCTION 
Background: Cardiovascular Disease, Diabetes, and Exercise 
Cardiovascular disease (CVD) remains the number one cause of death in the 
United States (Go et al., 2013). In the year 2009 more than 2150 Americans died of CVD 
related causes every day, averaging 1 death every 40 seconds (Go et al., 2013). 
Furthermore, in 2009 8.2 percent of the US population had diagnosed type 2 diabetes 
(T2D) and 38.2% of the population had pre-diabetes (Go et al., 2013). Both T2D and 
CVD are obesity related disorders and although the increase in the prevalence of obesity 
appears to have reached a plateau (Flegal, Carroll, Ogden, & Curtin, 2010), the US 
prevalence of ~35% is still very high (Flegal, Carroll, Kit, & Ogden, 2012). Finally, 
despite decades of public health recommendations (Haskell et al., 2007) and research 
unequivocally showing that exercise improves cardiovascular and metabolic health 
(Booth, Roberts, & Laye, 2012), estimates suggest that only 2-4% of adults in the US 
achieve the recommended goal of greater than 150 min/wk of moderate intensity physical 
activity, even when short 10 minute bouts are included (Troiano et al., 2008). 
High-intensity Interval Training 
The most commonly cited reason for adults not engaging in regular physical 
activity is a perceived lack of time (Godin et al., 1994; Stutts, 2002; Trost, Owen, 
Bauman, Sallis, & Brown, 2002). High-intensity interval training (HIT) is typically much 
shorter than standard continuous exercise and has recently appreciated a resurgence in the 
scientific literature showing comparable or superior improvements in fitness and 
cardiovascular disease (CVD) risk factors compared to conventional continuous moderate 
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endurance training programs (C. Earnest, 2009; Gibala, 2007; Kemi & Wisløff, 2010; 
Wisløff, Ellingsen, & Kemi, 2009). Furthermore, HIT has been shown to be more 
enjoyable than moderate-intensity continuous exercise (Bartlett et al., 2011). HIT may 
prove to be a time-efficient strategy for improving cardiovascular health, but 
effectiveness and sustainability of longer-term HIT interventions have not yet been 
evaluated (Gaesser & Angadi, 2011).  
Blood Glucose Control 
The treatment and prevention of type 2 diabetes with aerobic exercise is a well-
accepted approach (Balducci et al., 2008; Knowler et al., 2002). Hepatic and peripheral 
insulin resistance coupled with impaired β-cell function occurs long before fasting 
hyperglycemia and represents the early stages of the progression to T2D (DeFronzo, 
2009; S. Kahn, 2003; Lillioja et al., 1993). Obese, otherwise healthy, individuals (BMI ≥ 
30 kg/m2) are more susceptible to insulin resistance than their normal weight counterparts 
(B. B. Kahn & Flier, 2000). A relatively novel method of assessing blood glucose control 
or regulation, called continuous glucose monitoring (CGM), provides researchers with 
unprecedented granularity in assessment of blood glucose control (Klonoff, 2005). The 
CGM device provides blood glucose readings every five minutes for durations up to 72 
hours. A recent study showed abnormal glucose control in normal to overweight healthy 
men with abdominal obesity that was not detected with fasting glucose measurements 
(Ma et al., 2011). Furthermore studies on the effectiveness of acute high-intensity interval 
exercise (HIIE) on the control of blood glucose have shown promising results in diabetics 
(Gillen et al., 2012; S. F. Praet et al., 2006). A short-term (6 sessions) HIT program 
showed similar effectiveness (Little et al., 2011). There are currently no HIT 
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interventions longer than 4 weeks assessing changes in glucose control measured via 
CGM in obese adults.  
Endothelial Function 
 Improvements in traditional cardiovascular disease (CVD) risk factors including 
blood lipids, blood pressure, diabetes, weight, and hemostatic factors only account for 
~59% of the reduction in CVD events associated with exercise (D. H. J. Thijssen et al., 
2010). This discrepancy calls for assessment of novel and early markers of the 
atherosclerosis process. Decline in the capacity of the endothelial cells to produce NO has 
been shown to be an important indication of early atherosclerosis (Landmesser, Hornig, 
& Drexler, 2004). The use of high-resolution ultrasound to assess endothelial function via 
flow-mediated dilation (FMD) began in 1992 (Celermajer, Sorensen, & Gooch, 1992) 
and is now a popular research tool in assessment of endothelial function (McCully, 
2012). The amount of arterial dilation (FMD) that occurs after 5 minutes of blood flow 
occlusion has been shown to be a strong predictor of cardiovascular events in healthy 
subjects as well as subjects with known cardiovascular disease (Green, Jones, Thijssen, 
Cable, & Atkinson, 2011; Inaba, Chen, & Bergmann, 2010).  
Continuous and interval exercise training has been shown to improve FMD in 
healthy and diseased subjects (Clarkson et al., 1999; Hambrecht et al., 2003; Wisloff et 
al., 2007). Some studies suggest that HIT leads to superior improvements in FMD (Ciolac 
et al., 2010; Molmen-Hansen et al., 2012; Schjerve et al., 2008; A. Tjonna et al., 2009; A. 
E. Tjonna et al., 2008; Wisloff et al., 2007) while others show no difference between HIT 
and continuous training (Currie, Dubberley, McKelvie, & MacDonald, 2013; T. Moholdt 
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et al., 2011; Rakobowchuk et al., 2008). Therefore, the effectiveness of HIT compared to 
continuous exercise for improvement of endothelial function is unknown. 
Visceral Adipose Tissue 
It is well established that visceral adipose tissue (VAT) accumulation is linked to 
cardiovascular disease (J. P. Despres et al., 1990), hypertension (Rhéaume et al., 2009), 
endothelial function (Arcaro et al., 1999), hepatic insulin resistance (Gastaldelli et al., 
2000), impaired insulin secretion of pancreatic β-cells (S. Kahn, 2003), and peripheral 
insulin resistance (Mourier et al., 1997; Rhéaume et al., 2011). Aerobic exercise with and 
without caloric restriction and/or weight loss has proven to be effective in reducing VAT 
(Ismail, Keating, Baker, & Johnson, 2012; Kay & Singh, 2006). Some studies suggest 
that vigorous intensity exercise is superior to moderate or light intensity exercise in 
reducing VAT (Coker, Williams, Kortebein, Sullivan, & Evans, 2009; Irving et al., 
2008), while others show no difference between moderate and vigorous intensities (Cho, 
Lee, Lee, & Kang, 2011; Gutin et al., 2002; Kay & Singh, 2006; Nicklas et al., 2009; 
Ohkawara, Tanaka, Miyachi, Ishikawa-Takata, & Tabata, 2007; Slentz et al., 2005). A 
recent investigation found 15-weeks of HIT superior to steady state exercise in reduction 
of trunk adiposity, but VAT was not measured (E. Trapp, Chisholm, Freund, & Boutcher, 
2008). The effectiveness of HIT in the reduction of VAT is largely unknown and since 
some studies suggest that VAT reduction may be intensity dependent, research on HIT 
and VAT reduction is needed. 
Purpose, Specific Aims, and Hypotheses 
Purpose: Due to the lack of published long term studies using high-intensity 
interval training for the improvement of glucose control, artery function, and visceral 
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adiposity the purpose of this study was to compare the effectiveness of eight weeks of 
HIT to continuous exercise training in the improvement of these cardiovascular disease 
risk factors.  
Aim #1: To determine the efficacy of a novel, 8 week high-intensity aerobic 
interval exercise training program for improving blood glucose regulation in obese 
individuals. 
Hypothesis #1: I hypothesize that high-intensity interval training will yield 
superior improvements in blood glucose control compared to the continuous training. 
Aim #2: To determine the efficacy of a novel, 8 week high-intensity aerobic 
interval exercise training program for improving endothelial function in obese 
individuals. 
Hypothesis #2: I hypothesize that high-intensity interval training will yield 
superior improvements in endothelial function compared to the continuous training. 
Aim #3: To determine the efficacy of a novel, 8 week high-intensity aerobic 
interval exercise training program for decreasing visceral adipose tissue in obese 
individuals. 
Hypothesis #3: I hypothesize that high-intensity interval training will yield 
superior reductions in visceral adipose tissue compared to the continuous training. 
Definition of Terms 
High-intensity interval training: Exercise training characterized by short (6 
seconds to 6 minutes) periods of exercise at an intensity just below maximum separated 
by low-intensity recovery periods.  
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Continuous exercise training: Exercise training characterized by maintaining a 
constant workload for a sustained period of time. 
Continuous glucose monitoring: A method for assessing glucose control or 
regulation over 24-72 hours that utilizes a micro dialysis catheter inserted into adipose 
tissue that records blood glucose values every 5 minutes from the interstitial fluid. 
Endothelial function: Ability of the cells lining arteries to produce and release 
vasodilators, including nitric oxide, that in response to shear stress stimulate smooth 
muscle relaxation and vasodilation. 
Flow-mediated dilation: Used as a test of endothelial dependent vasodilation, 
artery diameter and blood flow are measured at rest, then again at peak flow and diameter 
after a five minute period of blood flow occlusion. 
Visceral adipose tissue: adipose tissue that accumulates around organs in the 
abdominal region and has a strong positive association with cardiovascular disease. 
Delimitations 
 The delimitations of the study for men and women include: body mass index of 
30 kg/m2 or greater, sedentary, non-smoking, not taking blood pressure, cholesterol, 
thyroid, or heart medications, no personal history of cardiovascular disease, and no 
physical disabilities or injuries not allowing them to engage in physical activity. 
Individuals must also have a clear acoustic window for optimal imaging of the brachial 
artery. Men must be between the age of 18 and 45 years and women between 18 and 55 
years. Women must not be pregnant or become pregnant and have less than 8 days of 
variation in their menstrual cycle from month to month.  
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Limitations 
The major limitation of this study is the lack of ability to control for dietary 
changes. We ask all participants to not intentionally change their diet, but we cannot be 
sure of their compliance. Similarly, we ask all participants to not engage in any regular 
vigorous physical activity outside of the intervention, but we cannot be sure of their 
compliance. We chose to not use a sedentary control group and to use the continuous 
exercise as a standard of care control due to metabolic deterioration typically seen in 
sedentary control groups (Patel, Slentz, & Kraus, 2011). Finally, only including 10 
subjects in each group provides sufficient statistical power for our primary outcome 
(glucose area under the curve), but may not provide statistical power for all of the 
outcomes measured.  
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Chapter 2 
BACKGROUND LITERATURE 
Endothelial Function 
Atherogenesis and the Progression of Atherosclerosis 
 It is now well recognized that the first step in the progression of atherosclerosis is 
endothelial cell dysfunction (Vanhoutte, 2009). Endothelial cell dysfunction is caused by 
direct injury to the vascular endothelium (Croce & Libby, 2007). The endothelial injury 
is caused and/or worsened by high levels inflammatory mediators and cytokines, high 
levels of low-density lipoproteins (LDL), hypertension, high blood glucose, high 
homocysteine, genetic changes, or free radicals caused by smoking (Croce & Libby, 
2007; Ross, 1999; Vanhoutte, 2009). Endothelial cells are formed early in development 
and remain quiescent for many years until advanced age and programmed cell death 
cause their turnover. After turnover the endothelial cells are quickly regenerated, but 
unfortunately the regenerated endothelial cells are dysfunctional. This turnover and 
replacement of healthy endothelial cells with dysfunctional cells is part of the natural 
ageing process, but it is accelerated when cardiovascular disease risk factors are elevated 
as in hypertension, hypercholesterolemia, and hyperglycemia (Vanhoutte, 2009). 
Dysfunction of the endothelium is characterized by a decrease in the ability of endothelial 
cells to produce (via endothelial nitric oxide synthesis [eNOS]) and release nitric oxide 
(NO). NO has many protective roles in the vascular system including: preventing 
abnormal constriction of the coronary arteries, inhibition of the expression of vascular 
and intracellular adhesion molecules (VCAMs and ICAMs) on the endothelium, which 
lead to adhesion and penetration of monocytes from the immune system (macrophages), 
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and inhibition of endothelin-1 (which has been shown to cause vasoconstriction and 
lymphocyte transformation into macrophages). The normal protective release of NO is 
stimulated by the presence of thrombin and other platelet aggregators, but in endothelial 
dysfunction the presence of these substances does not lead to adequate NO release. 
Inadequate NO release starts the process of atherogenesis by allowing platelet 
aggregation, increased permeability of the endothelium to leukocytes, a shift toward the 
domination of pro-coagulation substances, increased oxidation of LDL particles by the 
uncoupling of eNOS, increased release of pro-inflammatory cytokines, and the release of 
growth factors (Ross, 1999). 
Leukocytes are stimulated to migrate through the endothelial layer into the arterial 
intima where they differentiate into macrophages. The macrophages then release many 
inflammatory mediators leading to the formation of a pro-inflammatory milieu in the 
intimal layer of the artery. This pro-inflammatory milieu leads to the migration and 
proliferation of smooth muscle cells and the engulfing of accumulated oxidized LDL 
particles by macrophages which initiates their transition into foam cells and the formation 
of the fatty streak (Croce & Libby, 2007). Also extracellular matrix proteins such as 
collagen and elastin accumulate in the region causing the plaque to grow and harden. 
Eventually the inflammatory milieu transitions from an active growth site to a thick 
collagenous formation that is characterized by hypoxia which leads to necrosis and 
apoptosis. Cell death eventually leads to thinning of the fibrous cap and eventual rupture 
of the plaque thereby exposing the collagenous interior of the plaque as well as tissue 
factor to the blood stream. Both tissue factor and collagen lead to rapid coagulation 
which stays locally around the plaque. The coagulation leads to further growth of the 
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plaque and therefore further narrowing of the vessel lumen. Eventually a plaque rupture 
will lead to coagulation that blocks that particular vessel or an embolus will form leading 
to the blockage of a distant blood vessel resulting in myocardial infarction or stroke 
(Croce & Libby, 2007; Ross, 1999; Vanhoutte, 2009). The overview above outlined the 
pathogenesis of atherosclerosis which is the root of the number one cause of death in the 
United States (Go et al., 2013). Much research has focused on clinical assessment tools to 
recognize the earliest sign of atherosclerosis: endothelial dysfunction. The most widely 
used technique is the assessment of flow-mediated dilation (FMD) (McCully, 2012). 
First Flow-mediated Dilation Study 
In 1992 Celermajer and colleagues (1992) published their landmark study in 
Lancet showing the assessment of endothelial function and dysfunction via measurement 
of the femoral and brachial arteries with high resolution ultrasound. This study was the 
first to utilize a non-invasive measurement of endothelial function and therefore provided 
potential insight into the early stages of atherosclerosis (Vanhoutte, 2009). This elegant 
new measurement was grounded in a long line of experiments that took place over the 12 
years prior to this seminal publication. 
Importance of Endothelial Cells  
The health of endothelial cells lining arteries is one of the most important factors 
in the onset and progression of atherosclerosis leading to CVD (Vanhoutte, 2009). The 
importance of vascular endothelial cells for normal vasodilation was first recognized in 
the early-1980s with a series of Nobel Prize winning experiments using excised animal 
arteries (Furchgott & Zawadzki, 1980). In these experiments excised rabbit aortas were 
stimulated by acetylcholine with the endothelium intact or with the endothelial cells 
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destroyed by mechanical rubbing of the interior surface of the artery. Under the intact 
endothelium condition normal vasodilation via relaxation of smooth muscle occurred. 
Conversely, under the destroyed endothelium condition no relaxation of smooth muscle 
occurred. The authors concluded that a healthy endothelial cell lining is obligatory for 
vasodilation to occur (Furchgott & Zawadzki, 1980). Furchgott and others confirmed 
their findings in rabbit aortas with follow-up studies in many mammal species (1983).  
Discovery of Nitric Oxide  
Furchgott speculated that a potent vasodilator substance or substances termed 
endothelium derived relaxing factors (EDRFs) were produced and released by healthy 
endothelial cells to lead to vasodilation (1983). Many subsequent experiments were 
conducted exploring different substances (Prostanoids, acetylcholine, adenosine 
diphosphate, thrombin, and others) that could play the role of the EDRFs. In the mid-
eighties Palmer and colleagues (1987) provided strong evidence that NO was the most 
dominant EDRF.  Their first study used endothelial cell free rabbit aortas and stimulated 
vasodilation by either infusing NO or by infusing EDRF from porcine endothelial cells. 
Interestingly, both stimuli led to very similar vasodilatory responses. Furthermore, they 
showed that the amount of NO released by the porcine endothelial cells could 
quantitatively account for the amount of vasodilation that occurred (R. Palmer et al., 
1987). Therefore, it became clear that NO was the major EDRF (Moncada, Radomski, & 
Palmer, 1988). Palmer and colleagues were also the first group to show the amino acid L-
arginine as the direct precursor to NO (1988). 
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Blood Flow-mediated Vasodilation  
From the early studies of endothelial cells and EDRFs it was clear that certain 
chemicals (i.e. acetylcholine) could stimulate the release of EDRFs, but it was not until 
the mid-1980s that the role of blood flow in the modulation of vasodilation came into 
focus (Pohl, Holtz, Busse, & Bassenge, 1986; Smiesko, Kozik, & Dolezel, 1985). By 
inserting arterial catheters into canine arteries to measure diameter while blood flow was 
meticulously increased or decreased it was clear that increases in blood flow led to 
vasodilation and decreases in flow led to constriction (Pohl et al., 1986). These authors 
coined the term “flow mediated dilation” or FMD. In these same experiments the authors 
destroyed the endothelial cells by a balloon catheter and found that without endothelial 
cells no FMD occurs. Therefore, it was concluded that endothelial cells play the key 
regulatory role in flow mediated dilation.  
Shortly after these early FMD studies a series of elegantly designed experiments 
led to the discovery of mechano-receptors on the luminal surface of endothelial cells 
(Cooke, Rossitch Jr, Andon, Loscalzo, & Dzau, 1991; Lansman, Hallam, & Rink, 1987; 
Olesen, Claphamt, & Davies, 1988). When stimulated by shear stress, due to an increase 
in blood flow, these mechano-receptors lead to the opening of ion channels causing 
hyperpolarization of the endothelial cells. Hyperpolarization of endothelial cells leads to 
the phosphorylation of endothelial cell nitric oxide synthase (eNOS) which leads to an 
increase in the production of NO (Boo et al., 2002; Dimmeler et al., 1999; Fisslthaler, 
Dimmeler, Hermann, Busse, & Fleming, 2000). Follow-up studies provided strong 
evidence to solidify the link between blood flow, shear stress, eNOS activation, and NO 
levels (Berdeaux et al., 1994; Tuttle et al., 2001).  
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Is the Flow-mediated Dilation Technique in Large Conduit Arteries NO Dependent?  
Since most of the early studies that led to the conclusion that arteries respond to 
shear stress by vasodilation were conducted in excised animal vessels or smaller 
resistance vessels it was necessary to justify the assessment of flow-mediated dilation in 
conduit arteries. Two early studies provided this justification by showing a clear FMD 
response to ischemic conditions in brachial arteries (E. A. Anderson & Mark, 1989) and 
large coronary vessels (Nabel, Selwyn, & Ganz, 1990). Still the critical assumption that 
underlies the FMD assessment technique utilized by Celermajer et al (1992) is that the 
vasodilation that occurs in these conduit arteries is NO dependent. Evidence for this 
assumption was found by two studies utilizing a non-selective inhibitor of nitric oxide 
synthase (NG monomethyl-L-arginine [L-NMMA]). Joannides et al (1995) measured 
radial artery blood flow before and after 3 minutes of blood flow occlusion once under 
normal physiologic conditions then again during infusion of L-NMMA. There was a 
significant increase in blood flow observed without L-NMMA infusion that was 
completely abolished with infusion of L-NMMA. These results were replicated and 
expanded in a subsequent study that showed 5 minutes of blood flow occlusion led to 
completely NO dependent FMD, but 15 minutes of occlusion led to an FMD response 
that was not blocked by infusion of L-NMMA (Mullen et al., 2001). Therefore, it is now 
generally well accepted (see (K. Pyke et al., 2010) for one study with conflicting results) 
that the FMD response seen in conduit arteries after five minutes of blood flow occlusion 
is nitric oxide dependent.  
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Brachial Artery Flow-mediated Dilation: Clinical Relevance 
Assessment of brachial artery flow-mediated dilation (BAFMD) has become an 
extremely popular measurement in cardiovascular research. In 2011 alone 199 peer 
reviewed papers were published using BAFMD (McCully, 2012).  Soon after the first 
BAFMD paper was published the clinical relevance of the ability of the brachial artery to 
dilate was questioned. In an elegant study by Anderson and colleagues (1995) the 
relationship between BAFMD and coronary artery FMD was explored. Patients first 
underwent a coronary catheterization with direct measurement of flow-mediated 
vasodilation via infusion of acetylcholine. Next, within 24 hours of the catheterization 
procedure subjects underwent measurement of BAFMD. The authors found a very close 
relationship between BAFMD and coronary artery FMD. The ability of the BAFMD test 
to predict coronary FMD was 95%. Therefore, the health of the endothelial cells in large 
peripheral conduit arteries like the brachial artery is closely related to that of the coronary 
arteries. Furthermore, measurement of BAFMD is a well-established technique in the 
assessment of CVD risk in healthy and clinical populations (Inaba et al., 2010; D. H. J. 
Thijssen et al., 2010). A recent meta-analysis including 14 cohort studies totaling 5,547 
subjects clearly showed the importance of FMD assessment in prediction of future CVD 
events. The compiled evidence showed that for every 1% or 1 standard deviation decline 
in FMD there is an 8% or 22% increase in the risk of a future CVD event, respectively 
(Inaba et al., 2010).  
Brachial Artery Flow-mediated Dilation Methodological Considerations 
Due to its ease of use, cost-effectiveness, and non-invasive nature BAFMD is now 
commonly assessed by use of high resolution B-mode ultrasound. The assessment of 
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BAFMD is conducted by imaging the brachial artery at rest for one minute to establish a 
baseline reading. The baseline reading is followed by occlusion of blood flow in the 
forearm by a blood pressure cuff inflated to 250 mmHg for five minutes. After four 
minutes of occlusion imaging begins again and continues for three to five minutes after 
cuff release (at 5 minutes) (D. H. J. Thijssen et al., 2010). The recorded images are then 
analyzed using specialized analysis software which detects artery diameter and blood 
flow velocity then calculates shear rate and blood flow (Woodman et al., 2001). The 
resulting FMD value is arrived at by calculating the percent increase in artery diameter 
from the pre-cuff occlusion baseline video to the peak diameter measured post cuff-
release. BAFMD has been shown to be a stable and reliable assessment tool in many 
different laboratories (Hijmering et al., 2001; D. H. J. Thijssen et al., 2010; Welsch, 
Allen, & Geaghan, 2002).  
Conversely, some authors have questioned the reliability, standardization, and 
validity of flow-mediated dilation due to the high variability seen within subjects (Peretz 
et al., 2007) and the fact that small methodological changes can lead to large changes in 
the outcome (Black, Cable, Thijssen, & Green, 2008; Mullen et al., 2001). Hijmering et 
al (2001) has pointed out the high variability of BAFMD response within subjects and 
concluded that it is useful to see group differences but not sensitive enough to detect 
individual changes. This critique is likely overly critical due to the many studies that have 
accurately assessed changes in FMD on an individual level (D. H. Thijssen et al., 2010). 
Nonetheless, BAFMD assessment in the research setting needs more standardization (R. 
A. Harris, Nishiyama, Wray, & Richardson, 2010; Hijmering et al., 2001; Peretz et al., 
2007; D. H. J. Thijssen et al., 2010).  
16 
It has recently been demonstrated that the quantification of shear stress in the 
FMD response is likely very important to capture the whole picture of endothelial 
function (Padilla et al., 2008; K. E. Pyke, Dwyer, & Tschakovsky, 2004; K. E. Pyke & 
Tschakovsky, 2005; K. E. Pyke & Tschakovsky, 2007). Shear stress is the physiological 
stimulus that leads to the production and release of NO leading to the FMD response. 
Since shear stress is quantified from the product of blood flow velocity and artery 
diameter, assuming that blood viscosity remains constant, it has been shown that shear 
stress decreases significantly with increasing artery diameter (D. H. J. Thijssen et al., 
2010). Average, peak, and area under the curve shear stress have all been recommended 
to normalize the FMD measurement. Due to conflicting results (G. Birk et al., 2012; 
Green et al., 2013; K. E. Pyke & Tschakovsky, 2007) and statistical errors elicited by 
improper use of normalization ratios (Atkinson et al., 2009) the current guidelines 
recommend reporting shear rate AUC from cuff release to peak diameter, but 
normalization is not recommended. 
Other important technical considerations include occlusion duration, cuff 
placement, pre- or post-occlusion baseline diameter assessment, time-course 
measurement of artery diameter and blood flow velocity, and sonographer training. It has 
been shown that longer than 5 minutes of cuff occlusion leads to a non-NO dependent 
vasodilation (Mullen et al., 2001), therefore 5 minutes of occlusion is recommended for 
measurement of endothelium dependent dilation. Some early FMD studies utilized 
proximal (to the ultrasound probe) cuff placement instead of distal. One study showed a 
7% FMD in response to distal cuff placement that was completely blocked by L-NMMA, 
but a 12% FMD in response to proximal cuff placement that was only partially blocked 
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by L-NMMA (Doshi et al., 2001). Some authors have reported FMD using post-cuff 
occlusion baseline diameter instead of the true resting diameter (Magen et al., 2005). The 
problem with using post-occlusion baseline diameter is that it has been shown that the 
artery responses to occlusion differ depending on the age of the subjects (D. H. Thijssen 
et al., 2008). Young subjects tend to slightly dilate during occlusion therefore lowering 
the calculated FMD percentage whereas older subjects do not respond to occlusion. 
These heterogeneous results to cuff occlusion call for standardization in the use of pre-
cuff occlusion baseline in all studies (D. H. J. Thijssen et al., 2010). Due to the lack of 
sophisticated edge detection software and continuous image capture technology the early 
FMD studies (Celermajer et al., 1992) assessed baseline and peak diameter at set time 
points (i.e. 60 or 90 seconds). This technique of peak diameter assessment has been 
shown to potentially lead to the underestimation of FMD by 25-40% due to missing true 
peak diameter (Black et al., 2008). Logically, it is now recommended to measure artery 
diameter over the full time course of 180 seconds post-occlusion using advanced edge 
detection software (D. H. J. Thijssen et al., 2010; Woodman et al., 2001).  The most 
challenging aspect of the FMD technique is acquisition of a clear image of the brachial 
artery walls. The most current methodological guidelines suggest that sonographers 
obtain at least 100 practice FMD assessments before their participation in research using 
this technique (R. A. Harris et al., 2010; D. H. J. Thijssen et al., 2010). 
Many subject preparation considerations need to be addressed when using the 
FMD technique. FMD can be significantly affected by dietary intake (Tyldum et al., 
2009), recent exercise (G. Birk et al., 2012), caffeine (Papamichael et al., 2005), alcohol 
(Hijmering, De Lange, Lorsheyd, Kraaijenhagen, & Van De Wiel, 2007), vitamin 
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supplements (Eskurza, Monahan, Robinson, & Seals, 2004), medications (Magen et al., 
2005), and menstrual cycle stage (Hashimoto et al., 1995) therefore it is necessary to 
adequately control for all of these potential confounders when using the FMD technique.  
Recent literature on endothelial function and psychological factors suggests that 
some of the high variability seen with BAFMD could be due to uncontrolled variables 
such as stress, anger, and happiness (Ghiadoni et al., 2000; Gottdiener et al., 2003; C. W. 
Harris et al., 2000; Miller et al., 2006; Shimbo et al., 2007; Spieker et al., 2002). Stress 
and anger have been shown to negatively affect BAFMD (Ghiadoni et al., 2000; 
Gottdiener et al., 2003; C. W. Harris et al., 2000; Miller et al., 2006; Shimbo et al., 2007; 
Spieker et al., 2002). Shimbo et al (2007) showed complete abolishment of BAFMD due 
to anger provocation (from 7.5% at baseline to 0.6% 90 minutes after anger provocation). 
Another study by Spieker et al (2002) showed that BAFMD decreased from 8.0% at 
baseline to 4.1% after induction of mental stress. Conversely, laughter brought on by 
watching a comical film has been shown to improve BAFMD by up to 22%, whereas 
watching a stressful movie can decrease BAFMD by 35% (Miller et al., 2006; Sugawara, 
Tarumi, & Tanaka, 2010). These psychological factors can be partially controlled by the 
recommended standard procedure of having subjects lay quietly in a dark room for 20 
minutes before the BAFMD assessment begins (D. H. J. Thijssen et al., 2010).  
The Impact of Aerobic Exercise on Endothelial Function 
The arterial response to exercise training is characterized by immediate and short-
lived functional improvements in vasodilatory capacity in response to increased shear 
stress brought on by aerobic exercise. These improvements begin within the first week or 
two of training and reach a plateau by the fourth week. After the fourth week of training 
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the arteries show marked structural changes leading to increased artery diameter that may 
plateau by the 8th week of training. Once the artery diameter is increased the shear stress 
levels will normalize thus allowing vasodilatory function to return to baseline levels 
(Tinken, Thijssen, Black, Cable, & Green, 2008).  
Clarkson et al (1999) assessed FMD in 25 healthy male military recruits before 
and after ten weeks of aerobic exercise training. The exercise training elicited a 78% 
improvement in FMD showing that the vasculature of young healthy men of average 
fitness levels can be improved by aerobic exercise training. Conversely, this effect may 
not be seen in older healthy subjects. Eight weeks of cycle training led to no 
improvement in FMD in older men (D. Thijssen, De Groot, Smits, & Hopman, 2007). 
Although there is some controversy regarding the effects of exercise training on FMD in 
healthy populations (Green, Maiorana, O'Driscoll, & Taylor, 2004; Green et al., 2013), 
most studies using aerobic exercise interventions in patients with CVD, diabetes, or risk 
factors for these diseases show improvements in FMD (D. H. Thijssen et al., 2010).  
A host of recent studies have used exercise training in patients with severe CVD 
and seen drastic improvements in endothelial function. An elegant study by Hambrecht 
and colleagues (2003) exemplified the powerful effect that exercise training can have on 
endothelial function in CVD patients and elucidated potential mechanisms for these 
improvements. They examined the effects of 4 weeks of exercise (60 min moderate 
intensity 7d/wk) on the left internal mammary artery (LIMA) of patients scheduled for 
coronary bypass surgery. The exercise intervention improved endothelium dependent 
vasodilation in the LIMA as assessed by acetylcholine (~100% increase) and adenosine 
(~150% increase; suggesting improvement in flow dependent dilation) responses in vivo. 
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The authors also assessed dilatory responses in vitro finding large improvements in 
dilation that were coupled with increases in eNOS mRNA (100%) and eNOS protein 
expression (200%). This was the first study to confirm the positive effects of exercise on 
NO expression and availability that was most likely stimulated by the shear stress 
induced via exercise. This study brought to light the mechanism of upregulation of eNOS 
in response to exercise training. Wisloff et al (Wisloff et al., 2007) randomized 27 men 
and women with post-infarction heart failure to 12 weeks of 3 d/wk of continuous 
exercise (47 min @ 70% VO2peak), interval training (4x4’ intervals at 90% VO2peak), or 
a control group. After the training both exercise groups improved FMD greater than the 
control group. Interestingly the interval-training group improved FMD to a greater extent 
(4-11%) than the continuous group (4-8%) suggesting that higher intensity exercise may 
be better for FMD improvement. A study in patients with peripheral artery disease 
showed that 6 weeks of aerobic exercise 3 days/wk led to an improvement in FMD from 
7.6 to 10.3% (Andreozzi, Leone, Laudani, Deinite, & Martini, 2007). A recent study by 
Hermann et al (2011) compared the effects of 8 weeks of high-intensity interval training 
versus a control group on FMD in stable heart transplant patients. The exercise group 
realized a significant improvement in FMD compared to the control group (3% 
improvement vs. no change).  
The studies discussed above clearly show that patients with advanced 
cardiovascular disease can show drastic improvements in endothelial function from 
exercise training interventions. Endothelial function has also been shown to improve in 
subjects with increased cardiovascular disease risk factors such as hypercholesterolemia, 
hypertension, diabetes, and obesity. Twenty-two hypercholesterolemic patients 
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underwent 8 weeks of combined aerobic and resistance training or a control condition 
(Walsh et al., 2003). The subjects in the exercise group showed significant improvements 
in both FMD and the forearm blood flow response to acetylcholine demonstrating 
improvements in both resistance and conduit vessels that were not seen in the control 
group. Fifty-four elderly hypertensive patients with systolic 24-hour ambulatory blood 
pressure above 140 mm Hg were randomized to either 12 weeks of treadmill exercise or a 
control condition (Westhoff et al., 2007). The subjects in the treatment group had a 
significant improvement in FMD (5.6 to 7.9%). Diabetics have also been shown to 
greatly improve endothelial function in response to exercise training. Fifteen type 2 
diabetic subjects underwent 12 weeks of combined aerobic and resistance exercise 
training and realized improvements of endothelial function in both conduit (FMD 
increased from 1.7 to 5%) and resistance vessels (forearm blood flow response to 
acetylcholine). Schjerve et al (2008) randomized 40 obese adults to either moderate 
exercise training, high-intensity interval training, or strength training for 12 weeks and 
assessed endothelial function before and after the intervention. Flow-mediated dilation 
was significantly improved in all three groups, but improved to a greater extent in the 
high-intensity interval training group.  
Taken together the above studies show that aerobic exercise training can elicit 
drastic improvements in endothelial function in populations ranging from young healthy 
men to and men and women with severe heart failure and CVD.  
High-intensity Interval Training in the Improvement of Endothelial Function 
A thorough review of the literature on high-intensity interval training and 
endothelial function yields a limited number of studies. Only eight human subject 
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exercise interventions that directly compared HIT to another form of exercise training for 
the improvement of endothelial function could be found (Ciolac et al., 2010; Currie et al., 
2013; T. Moholdt et al., 2011; Molmen-Hansen et al., 2012; Schjerve et al., 2008; A. 
Tjonna et al., 2009; A. E. Tjonna et al., 2008; Wisloff et al., 2007). Of these eight 
exercise interventions six showed HIT to be superior to moderate or continuous exercise 
training for the improvement in endothelial function (Ciolac et al., 2010; Molmen-
Hansen et al., 2012; Schjerve et al., 2008; A. Tjonna et al., 2009; A. E. Tjonna et al., 
2008; Wisloff et al., 2007) and two showed improvements in both groups with no group 
difference (Currie et al., 2013; T. Moholdt et al., 2011). Interestingly six of the eight 
articles were written by the same research group (T. Moholdt et al., 2011; Schjerve et al., 
2008; A. Tjonna et al., 2009; A. E. Tjonna et al., 2008; Wisloff et al., 2007). One study 
compared sprint interval training (4-6 wingates, 3 times/wk) to continuous endurance 
exercise (40-60 min at 65% of VO2max) in young healthy subjects and saw similar 
improvements in FMD in both groups (Rakobowchuk et al., 2008). Two other studies 
using heart transplant patients (Hermann et al., 2011) and post-stent procedure patients 
(Munk, Staal, Butt, Isaksen, & Larsen, 2009) that did not use a comparison or a control 
group showed substantial improvements in endothelial function in response to HIT.  
The most robust of the randomized trials comparing HIT to other interventions is 
perhaps the RCT conducted by Wisloff et al in heart failure patients (2007). The most 
striking finding of this study was the fact that the drastic improvement in FMD elicited 
by the continuous exercise (2 fold increase) was actually surpassed by the improvement 
in the HIT group (2.75 fold increase). The only study directly comparing HIT with 
moderate exercise and strength training in obese adults for the improvement in 
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endothelial function was a 12-week intervention conducted in Norway (Schjerve et al., 
2008). Forty subjects were randomized to each of the three groups for 3 days/wk of 
supervised exercise. After the 12-week intervention FMD improved in all three groups, 
but the HIT groups improved significantly more than the other two exercise groups. 
Similarly, 35 metabolic syndrome patients were randomized to 16 weeks of either HIT or 
moderate aerobic exercise training for 3 days a week (A. E. Tjonna et al., 2008). Both 
groups had significant improvements in FMD, but the HIT group (5 to 14%) improved 
more than the moderate group (4-8%). HIT has also been shown to be more effective for 
the improvement in endothelial function than a multi-treatment centered approach 
(consisting of moderate exercise, group meetings, as well as physical, psychological, and 
nutritional therapy in overweight and obese adolescents (A. Tjonna et al., 2009). After 
the 12-month intervention the HIT group improved FMD from 6-12% whereas the multi 
treatment group did not significantly improve FMD. Another study randomized 44 
healthy women who had a family history of hypertension to16 weeks of HIT or 
continuous exercise (Ciolac et al., 2010). After the 16-week intervention the HIT group 
significantly lowered their endothelin-1 levels and significantly increased their NO levels 
to a greater extent than the continuous group, both factors demonstrating improvements 
in endothelial cell health. The only study from the Norwegian group that did not show 
HIT to be superior for the improvement in endothelial function was a 12-week RCT 
comparing usual cardiac rehabilitation to HIT in post myocardial infarction patients (T. 
T. Moholdt et al., 2009). Both the HIT and the usual care groups had improvements in 
FMD of approximately 2.5 to 3.0% in absolute terms. The authors explained that the 
usual care was more intense than the moderate exercise training in their previous studies 
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and that may have been the reason for the lack of dominance in the HIT group. Lastly, 
the most recent study comparing HIT to continuous exercise randomized 22 subjects with 
documented coronary artery disease to 12 weeks of 2 days/week of HIT (10-1 minute 
intervals at 89% of peak power separated by 1 minute of recovery) or continuous cycling 
(30-50 min at 58% of peak power) plus each group completed one day/week of 
continuous exercise on their own (Currie et al., 2013). After the 12-week intervention 
both groups improved FMD significantly (~1.5-2% absolute increase), but there was no 
difference between HIT and continuous exercise.  
The results from the available data on the role of HIT in the improvement of 
endothelial function suggest that HIT may be superior to continuous exercise training. 
The potential mechanism for a greater improvement in endothelial function is the higher 
level of shear stress induced by HIT compared to moderate intensity exercise leading to 
greater stimulus on the endothelial cells. Twelve weeks of HIT was shown to increase 
antioxidant capacity and reduce oxidized LDL in heart failure patients more than 
moderate exercise (Wisloff et al., 2007). Similarly, three weeks of interval exercise 
improved NO availability more than continuous exercise (Deljanin Ilic et al., 2009). 
Lastly, a metabolic syndrome rat model study showed that HIT improved endothelial 
function, HDL, eNOS, endothelial cell caveolae, insulin action, free fatty acid uptake, 
and lipolysis more than continuous exercise (Haram et al., 2009). Therefore, potential 
mechanistic studies do exist to explain a superior improvement with HIT, but much more 
research is needed in this area. The small number of direct comparison studies in humans 
shows the need for more research of this type as well. The fact that only one study has 
been conducted in obese subjects comparing HIT to continuous exercise for the 
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improvement in endothelial function signifies a great need for research in obese subjects. 
The next section will focus on the potential physiological mechanisms for the 
improvement in endothelial function with exercise training with a special consideration 
for high-intensity interval training.  
Mechanisms for the Improvement of Endothelial Function with Exercise 
The improvements in endothelial function realized by exercise training are 
hypothesized to be largely induced by the increases in shear stress brought on by exercise 
(G. K. Birk et al., 2012; Dimmeler et al., 1999; Green et al., 2004; Green, 2009; Lenk, 
Uhlemann, Schuler, & Adams, 2011; Ribeiro, Alves, Duarte, & Oliveira, 2010; Tinken et 
al., 2009). Acutely shear stress in the form of increased anterograde flow was shown to 
improve BAFMD in response to heating, handgrip exercise, and cycling (Tinken et al., 
2009). Interestingly, in this same study the other arm had the shear rate manipulated by 
inflating a blood pressure cuff to 60 mmHg during each of the three interventions, 
therefore causing an increase in retrograde flow. Instead of increasing BAFMD like in the 
non-cuffed arm, the FMD response in the cuffed arm was actually decreased. A similar 
effect was seen with eight weeks of exercise training (G. K. Birk et al., 2012). In this 
elegantly designed study young healthy men underwent eight weeks of cycle exercise 
with a blood pressure cuff on one arm during each exercise session. Each two weeks of 
the intervention BAFMD was assessed in each arm. A significant increase in BAFMD 
was observed at 2 weeks in the non-cuffed arm, but the cuffed arm did not improve FMD 
at any time point over the 8 week intervention. These two studies underscore the 
importance of shear stress in the adaptations that occur in endothelial function in 
response to exercise training. Besides the direct role of increased shear stress, exercise 
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has been shown to improve multiple risk factors that induce an indirect effect on 
endothelial function (Haram et al., 2009; Ribeiro et al., 2010). The subsequent sections 
will be dedicated to discussing the potential mechanisms by which increased shear stress 
and reduced CVD risk factors lead to improvements in endothelial function. The main 
theory for the increased endothelial cell function due to exercise revolves around 
increased nitric oxide availability (Green et al., 2004). Increased nitric oxide availability 
can occur by one or more of the following mechanisms: 1) Decreased reactive oxygen 
species (ROS), 2) Improved antioxidant capacity, 3) Increased eNOS activation and 
expression, 4) Decreased endothelial cell death, or 5) Improvements in endothelial 
progenitor cell level and function.  
Antioxidant effect of exercise. Exercise training has been shown to exert an 
antioxidant effect (Adams et al., 2005; Edwards et al., 2004; Goto et al., 2007; Rush, 
Laughlin, Woodman, & Price, 2000; Wisloff et al., 2007). A hallmark of endothelial 
dysfunction is the endothelial expression of angiotensin II which leads to 
vasoconstriction and activation of a multi-enzyme complex known as NAD(P)H oxidase 
which causes a major increase in reactive oxygen species (ROS) formation (Adams et al., 
2005). In the presence of high levels of ROS, NO is degraded into an inactivated 
molecule (ONOO-). Furthermore, high levels of ROS lead to the oxidation of LDL 
particles in the artery intima. Oxidized LDL are readily engulfed by macrophages which 
eventually turn into foam cells leading to the inflammatory milieu of atherosclerosis 
which further decreases endothelial function (Ribeiro et al., 2010).   
Perhaps the most elegant study evaluating the antioxidant effects of exercise 
training involved 22 CAD patients with a history of at least 10 myocardial infarctions 
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each (Adams et al., 2005). Half of the patients were randomized to four weeks of 60 
minutes/day rowing or cycling in the hospital and half were randomized to the control 
group. After the intervention in vivo endothelial function improved by ~100% in the 
exercise group and did not change in the control group.  Since all of the subjects had 
elected to undergo coronary artery bypass surgery the researchers were able to harvest a 
portion of their left internal mammary artery (LIMA) before surgery (after the 4 week 
intervention). In vitro measurement of NAD(P)H oxidase subunits showed a 69% 
reduction in gp91phox mRNA (similar to statin use: 60% reduction), as well as decreases 
in other important subunits including p22phox and Nox4 which led to a 58% reduction in 
ROS formation. Also subjects in the exercise group showed a 77% lower level of AT1-R  
mRNA  and 46% lower protein expression compared to the control group (AT1-R is the 
major activation pathway between Ang II and NAD(P)H oxidase). Furthermore, AngII 
mediated vessel contraction decreased by 49%. Importantly, correlations between 
changes in in vivo endothelial function and protein expression and ROS generation were 
moderate to high (r = 0.63 to 0.80). This study clearly showed the powerful antioxidant 
effect of exercise in the reduction of ROS as well as vasoconstriction (Adams et al., 
2005). Another study showed that 12 weeks of aerobic exercise (3 days/wk, cycling or 
walking) led to increased FMD (7.9 to 11.1%), nitrite/nitrate, superoxide dismutase, and 
decreased oxidative stress in a group of CAD patients (Edwards et al., 2004). Another 
important mechanistic study showed that exercise training in pigs led to increases in 
super-oxide dismutase enzyme levels and activity in coronary vessels which would 
improve antioxidant capacity (Rush et al., 2000). 
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Exercise increases endothelial nitric oxide synthase. Increases in eNOS 
expression and activity have also been shown to be linked to the exercise induced 
increases in NO availability (Davis, Cai, Drummond, & Harrison, 2001; Delp & 
Laughlin, 1997; Haram et al., 2009; Sessa, Pritchard, Seyedi, Wang, & Hintze, 1994). 
The first study linking increases in shear stress to up-regulation and increased activation 
of eNOS was a well-designed study by Sessa and colleagues (1994). Ten days of two 
hours/day of exercise in dogs led to significant increases in NO release via acetylcholine 
infusion to the coronary arteries and micro vessels. The authors discovered the potential 
mechanism of this increase in NO by measuring an increase eNOS gene expression in the 
coronary vessels. These findings were confirmed and expanded on by others showing that 
the activation of eNOS from shear stress occurs via the akt dependent phosphorylation 
pathway (Dimmeler et al., 1999) and another study outlining the time course of these 
adaptations (Delp & Laughlin, 1997). This work was followed up in 2001 by a study that 
showed the short term effect of shear stress on eNOS is the upregulation of eNOS 
transcription and the long-term effect is the stabilization of eNOS mRNA (Davis et al.). 
A landmark study discussed above was the first to show the upregulation of eNOS in 
humans by use of the LIMA model in coronary artery bypass patients (Hambrecht et al., 
2003). In brief exercise training elicited a 100% increase in eNOS mRNA and a 200% 
increase in eNOS protein expression. Therefore there is strong and clear evidence that 
increases in shear stress via exercise lead to improvements in NO bioavailability via 
upregulation of eNOS.  
Endothelial Progenitor Cells. A relatively new area of research relating to 
improvements in endothelial function involves the reservoir of tissue specific stem cells 
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in the bone marrow and general circulation called the endothelial progenitor cells (EPCs) 
(Lenk et al., 2011). Individuals with cardiovascular disease have been shown to have 
decreased number and functional ability of these cells (Hoetzer et al., 2007; Lenk et al., 
2011; Steiner et al., 2005). Interestingly, it has been shown that shear stress in the bone 
marrow leads to activation of eNOS which leads to the activation, stimulation, and 
migration of EPCs to regenerate damaged vessels (Aicher et al., 2003). Therefore, the 
common mechanism of improved endothelial cell function via increases in shear stress 
also applies to the generation of new endothelial cells in the bone marrow (Lenk et al., 
2011). Consequently, it has been shown that physical activity increases the production 
and circulating number of EPCs via a partially NO-dependent pathway (Laufs et al., 
2004). Exercise has also been shown to increase the migratory ability of EPCs to the 
damaged endothelium (Lenk et al., 2011). 
EPCs are stimulated by acute exercise via release of PGC-1 α, hypoxia inducible 
factor-1, vascular endothelial growth factor, stromal cell derived factor-1, erythropoietin, 
and oxidative stress (which is essential for hypoxia or EPO induced mobilization of 
EPCs) (Lenk et al., 2011). Finally, it has been shown that the shear stress induced by 
exercise leads to inhibition of apoptosis of endothelial cells (Dimmeler, Haendeler, 
Rippmann, Nehls, & Zeiher, 1996) and EPCs (Melino et al., 1997). A study that used 
human umbilical venous endothelial cells showed the apoptosis induced by tumor 
necrosis factor α was completely blocked by shear stress (Dimmeler et al., 1996). It has 
also been shown that shear stress related release of NO in the bone marrow is crucial in 
regulating the balance between EPC apoptosis and necrosis and therefore producing 
healthy and functional EPCs (Melino et al., 1997). This exciting and new field of 
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research relating to endothelial function shows promise of possible pharmacological 
targets as well as another prominent mechanism by which exercise can improve artery 
function. 
Improvement in CVD Risk Factors Indirectly Effecting Endothelial 
Function. Finally, the last potential mechanism in which exercise can improve 
endothelial function is the indirect mechanism of improving cardiovascular disease risk 
factors that have an influence on endothelial cell health (Ribeiro et al., 2010). Exercise is 
known to improve inflammatory cytokines and markers of inflammation (Gaesser, 
Angadi, Ryan, & Johnston, 2012), increase high density lipoprotein (HDL) levels 
(Kodama et al., 2007), decrease LDL (Snowling & Hopkins, 2006), and improve glucose 
control (Snowling & Hopkins, 2006). Reduced LDL particles leads to less oxidized LDL 
in the arterial intima. High serum HDL levels have been shown to prevent the oxidation 
of LDL and increase eNOS activity thereby protecting endothelial cells (Young, Karas, & 
Kuvin, 2004). A reduction in inflammatory mediators causes a reduction in cellular 
adhesion molecules on the surface of endothelial cells leading to less inflammation in the 
artery walls and improved endothelial function (Ribeiro et al., 2010). Shear stress due to 
exercise has also been shown to directly reduce VCAM expression on endothelial cells 
(Ando et al., 1994). Lower glucose levels leads to lower oxidative stress which is directly 
related to NO availability and therefore endothelial function (De Vriese, Verbeuren, Van 
de Voorde, Lameire, & Vanhoutte, 2000). 
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Section 2: Blood Glucose Control 
Pathogenesis of Impaired Glucose Tolerance and Type 2 Diabetes 
The control of normal blood glucose levels depends on the dynamic interplay 
between three primary components and many other secondary components (DeFronzo, 
2009; S. Kahn, Suvag, Wright, & Utzschneider, 2012; Stumvoll, Goldstein, & van 
Haeften, 2005). The three primary components that dictate blood glucose levels are 
endogenous glucose release from the liver, glucose uptake by the tissues, and insulin 
release by the β-cells of the pancreas. 
The more complete picture of the determinants of glucose control includes the 
additions of adipocytes, pancreatic α-cells, the brain, the kidneys, and the digestive tract. 
These eight crucial components of glucose control have been called the ominous octet 
(DeFronzo, 2009). The natural history in the progression from normal glucose tolerance 
(NGT) to impaired glucose tolerance (IGT) to type 2 diabetes (T2D) involves a reduction 
in insulin sensitivity in the liver that leads to increased glucose production and secretion, 
a reduction in insulin sensitivity in the peripheral tissues (muscle, fat, and others), and a 
decline in pancreatic β-cell function (Jallut et al., 1990; Weyer, Bogardus, Mott, & 
Pratley, 1999). Both obesity (B. B. Kahn & Flier, 2000) and physical inactivity (Knowler 
et al., 2002) lead to insulin resistance which puts extra strain on the β-cells to produce 
and release more insulin to control blood glucose. Eventually the β-cells fail to 
compensate for the insulin resistance and the result is abnormal glucose levels.  
The description above is an over-simplified explanation of the progression of T2D 
since it has been clearly shown that β-cell dysfunction occurs early in the onset of IGT 
long before hyperglycemia ensues (S. Kahn, 2003). Furthermore, the sequence of events 
32 
moving from NGT to IGT to T2D differs by ethnicity (M. A. Abdul-Ghani et al., 2007), 
but the onset of diabetes is typically highly dependent on β-cell function (M. A. Abdul-
Ghani, Tripathy, & DeFronzo, 2006; DeFronzo, 2004; DeFronzo, 2009; S. Kahn, 2003). 
Pancreatic Β-Cell Function 
In order to truly assess β-cell function the change in glucose and insulin in 
response to a meal (oral glucose tolerance test: OGTT) plus the level of insulin resistance 
must all be accounted (DeFronzo, 2009). Simply measuring the plasma insulin response 
to a glucose challenge does not provide a valid measure of β-cell function. Therefore, the 
gold standard for measuring β cell function involves the measurement of the insulin 
secretion/insulin resistance index, also known as the disposition index (Delta 
Insulin/Delta Glucose ÷ Insulin resistance). In the upper range of NGT (120-139 mg/dl) 
for the 2 hour glucose level during an OGTT the disposition index reveals that even 
though glucose levels are considered “normal” these individuals have lost approximately 
two-thirds of their β-cell function. Furthermore, individuals in the upper end of IGT (180-
199 mg/dl at the 2 hour OGTT mark) have already lost 80-85% of their β cell function. 
Therefore before diabetes is even diagnosed the individual could have drastically 
impaired β-cell function (M. A. Abdul-Ghani et al., 2006; M. Abdul-Ghani, Jenkinson, 
Richardson, Tripathy, & DeFronzo, 2006; DeFronzo, 2009; Ferrannini et al., 2005; 
Gastaldelli, Ferrannini, Miyazaki, Matsuda, & DeFronzo, 2004).  
Evidence from deceased individuals also shows the importance of β-cell function 
in the early onset of IGT. Data from 124 autopsies showed that β-cell volume is ~50% 
lower in IGT subjects compared to NGT. The rate of β-cell apoptosis was 10 fold higher 
in lean diabetics and three-fold higher in obese diabetics compared to their non-diabetic 
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counterparts (Butler et al., 2003). Data from the Pima Indians in Arizona showed that the 
difference between individuals with IGT that transitioned to T2D and those that did not 
was their β-cell function (Weyer et al., 1999). In a sample of 150 overweight Latino 
children (mean age = 11 years) with a family history of T2D it was shown that 28% 
already had IGT and those with IGT had a 16% lower disposition index suggesting they 
already had impaired β-cell function (M. Goran et al., 2004). Therefore, β-cell 
dysfunction is not a part of T2D pathogenesis that occurs later in the disease progression, 
but it is seen very early in the onset of “Pre-Diabetes” and may represent the determining 
factor in the progression of the disease.  
Factors affecting β cell function include: advancing age, genetics, insulin 
resistance, lipotoxicity, glucotoxicity, amylin, and incretins. Β-cell function is found 
frequently in families and first degree relatives of individuals with T2D are much more 
likely to have diabetes (Stumvoll et al., 2005). Although the mechanistic basis is not yet 
well developed it is hypothesized that insulin resistance leads to progressive β-cell failure 
due to an “over-working” of the β-cells. Lipotoxcity can ensue when adipocytes become 
maximally filled with free fatty acids (FFAs) and they start to release FFAs into the 
circulation and these FFAs are absorbed and stored by many tissues around the body 
including skeletal muscle, heart, pancreas, liver, and the brain. This excess build-up of 
FFAs in non-adipocyte tissue leads to insulin resistance in those tissues as well as 
impaired insulin release from the pancreas (DeFronzo, 2009). Similarly, glucotoxicity 
from long-standing hyperglycemia will eventually lead to β-cell damage. Amylin or Islet-
Amyloid Poly Peptide (IAPP) which is co-secreted with insulin, has been found to build 
up in the β-cells and lead to decreased function. The evidence for this in humans is still in 
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its infancy, but amyloid area of the pancreas in baboons has been shown to predict β-cell 
function well (Guardado-Mendoza et al., 2009). Finally, very important stimulating 
agents for the release of insulin in response to food intake (account for 2/3 of insulin 
release) are the gut derived hormones known as incretins. The two dominant incretins are 
glucose-dependent insulinotropic polypeptide or GIP and glucagon-like peptide 1 or 
GLP-1. Normally release of incretins stimulates insulin release and blocks glucagon 
release. T2D causes a reduction in GLP-1 and resistance to GIP in the β-cells (Holst & 
Gromada, 2004).  
Insulin Resistance and Glucose Release in the Liver 
During the fasting state the brain accounts for 50% of the glucose uptake. This 
demand is met mostly by glucose production in the liver. Normal fasting glucose 
production is 2 mg/kg/min, but in individuals with T2D it is 2.5 mg/kg/min (amounting to 
~25-30 g extra/night). This high fasting glucose occurs in the presence of 2.5-3 fold 
higher insulin levels, therefore it is clear that hepatic glucose production and release are 
responsible for the higher fasting glucose levels (Consoli, Nurjhan, Reilly Jr, Bier, & 
Gerich, 1990; DeFronzo, Ferrannini, & Simonson, 1989). When the liver is not insulin 
resistant it responds to insulin by inhibiting the production and release of glucose, but in 
the insulin resistant state this mechanism is deficient leading to excess glucose release 
and production in the liver (DeFronzo et al., 1989). The extra glucose release from the 
liver is also caused by increased glucagon and enhanced hepatic sensitivity to glucagon 
(Baron, Schaeffer, Shragg, & Kolterman, 1987), lipotoxicity leading to increases in the 
rate limiting enzymes of hepatic gluconeogenesis (Gastaldelli et al., 2000), and 
glucotoxicity leading to increases in the rate limiting enzyme for glucose release from the 
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liver (Clore, Stillman, & Sugerman, 2000). All of these factors together lead to excess 
endogenous glucose production and release into the blood stream by the liver. 
Interestingly, it has been shown by use of insulin receptor knock-out models in mice that 
only when liver and β-cell insulin receptors are knocked out does it lead to 
hyperglycemia. The knock-out models for the muscle, adipocytes, and neurons led to no 
change in glucose control. Therefore, the insulin sensitivity of the liver is extremely 
important in the pathogenesis of T2D and may be the major factor in the control of blood 
glucose during fasting (Stumvoll et al., 2005).  
Insulin Resistance in the Skeletal Muscle 
Skeletal muscle insulin resistance could account for approximately 85-90% of the 
total body impairment of glucose uptake (DeFronzo, 2009). The most prominent aspect 
of insulin resistance in the muscle is the impairment of the post-binding effects of insulin 
(DeFronzo, 2004). The pathway of insulin leading to glucose transport into the muscle 
cell starts with insulin binding to receptor then phosphorylating key tyrosine portions of 
the β chain on the receptor. Phosphorylation results in insulin receptor substrate-1 (IRS-
1) moving to the cell membrane where is binds to the insulin receptor and PI 3-kinase and 
Akt which results in glucose being transported into the cell, but also activation of nitric 
oxide synthase leading to vasodilation and activation of lipid, protein, and glycogen 
synthesis (DeFronzo, 2009). In T2D the ability of IRS-1 to activate PI 3-kinase is 
severely impaired leading to not only the inability of GLUT 4 to transport glucose into 
the cell, but impaired activation of NOS leading to endothelial dysfunction, and 
impairment in glucose metabolism and glycogen synthesis. Interestingly, insulin 
normally inhibits mitogen activated protein kinase (MAP kinase), but in insulin resistance 
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MAP kinase does not become inhibited which leads to inflammation, atherosclerosis, 
lying down of collagen, and smooth muscle proliferation. Since there is so much insulin 
being released MAP kinase gets hyper-stimulated and this may explain a large portion of 
the connection between insulin resistance and atherosclerosis (DeFronzo, 2004; 
DeFronzo, 2009).  
Secondary Determinants of Blood Glucose Control 
The ability of the gastrointestinal tract to release incretins in response to a meal as 
well as the sensitivity of the pancreas to these molecules has also been shown to play a 
key role in insulin secretion and glucose control. For example GLP-1 is a strong inhibitor 
of glucagon release therefore inhibiting endogenous glucose release after a meal. GLP-1 
deficiency in T2D leads to a subsequent rise in blood glucose due to endogenous glucose 
release even after a meal. GIP is a potent stimulator of insulin release, but in T2D the β-
cells become resistant to its effects (Holst & Gromada, 2004). The pancreatic α-cells are 
responsible for the production and release of glucagon and fasting levels have been 
shown to be elevated in T2D. This slight glucagon elevation coupled with 
hypersensitivity to the hormone in the liver may be largely responsible for increases in 
fasting glucose levels (Baron et al., 1987). The kidneys of non-diabetic individuals have a 
certain level of glucose that they can filter out of the blood each day then reabsorb into 
the blood stream. Glucose that exceeds this maximal reabsorption rate is excreted in the 
urine. Animal models and in vitro kidney studies have shown drastically increased ability 
of the kidneys to reabsorb glucose in T2D. This is most likely an adaptation of the body 
to conserve glucose since the lack of glucose in cells signals a starvation state. Therefore 
the extra reabsorption of glucose by the kidneys also adds to hyperglycemia (DeFronzo, 
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2009).  Finally, the brain has recently been implicated as a key player in the 
hyperglycemia octet. It is hypothesized that the normal cerebral response to increasing 
insulin levels in the blood is appetite suppression, increased glucose uptake, and 
decreased gluconeogenesis stimulation in the liver. Conversely, in T2D there may be 
insulin resistance in the brain leading to a higher level of impaired glucose control.  
The Role of Inflammation in the Pathogenesis of Impaired Glucose Control 
Inflammation in the pancreas as well as systemically has been shown to be related 
to IGT and the onset of T2D (Donath & Shoelson, 2011; Pickup, 2004). One of the 
earliest inflammatory markers that was observed to be associated with IGT was tumor-
necrosis factor α (TNF-α). It was originally hypothesized that the enlarged adipocytes 
were the direct source of TNF-α, but now it is well accepted that most of the TNF-α 
comes from macrophages around adipocytes, hepatocytes, β-cells, and myocytes (Donath 
& Shoelson, 2011; Weisberg et al., 2003). Other pro-inflammatory cytokines and 
chemokines that are released from the macrophages and found to accumulate during 
obesity, IGT, and T2D are interleukin-1β (IL-1β), IL-6, and chemokine ligands 2, 3, and 
8 (CCL2, CCL3, and CXCL8) (Donath & Shoelson, 2011; Weisberg et al., 2003).  
Although macrophages are the most prevalent immune cell found in adipose 
tissue other studies have shown increases in mast cells and T-cells in patients with T2D. 
The increase in macrophages around adipocytes is most likely caused by hypoxia and cell 
death. Hypoxia in adipose tissue is mostly likely caused by rapid fat cell growth and 
proliferation in which angiogenesis cannot keep up with. Therefore, the expanding 
adipose tissue becomes slightly hypoxic. Hypoxia stimulates macrophages to accumulate 
in the area which eventually lead to angiogenesis, but in the early term leads to a pro-
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inflammatory state. This hypoxia also leads to cell death in which macrophages aggregate 
around dead adipocytes forming crown-like structures and releasing many pro-
inflammatory mediators (Donath & Shoelson, 2011). Furthermore, activation of the NF-
kβ and JNK pathways brought about by toll-like receptors (TLRs), FFAs, and advanced 
glycation end-products associated with IGT and T2D also leads to release of more pro-
inflammatory cytokines which cause insulin resistance in the tissues from which they 
originate (liver, adipocytes, etc) as well as affect other tissues including blood vessels, 
cardiac and skeletal muscle, and leukocytes. Therefore, the immune system involvement 
in IGT and T2D is well documented, but extremely complex. The mechanisms involve 
many different pathways, cytokines, chemokines, and adipokines that are all involved in 
the causes of pancreatic β cell dysfunction as well as central and peripheral insulin 
resistance (Donath & Shoelson, 2011; Pickup, 2004). 
The Use of Continuous Glucose Monitoring to Assess Glucose Control 
Early continuous glucose monitoring technology began in the 1960s with 
intravenous catheters that recorded blood glucose levels every 1 second to every 15 
minutes. This method was associated with significant risk of infection as well as 
thrombosis. Improvements made over the past 20 years have led to the development of 
glucose devices that sample from the interstitial space, are less invasive, and have much 
lower incidence of complications. Modern continuous glucose monitors use a micro-
dialysis catheter that is inserted subcutaneously. The sensor contains an enzyme-based 
electrode (glucose oxidase) that detects current created by the oxidation of glucose and 
oxygen to create hydrogen peroxide. The oxidation of glucose via glucose oxidase 
removes one electron from each glucose molecule which results in a measureable 
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electrical current that can be converted into a blood glucose value (Penfornis, Personeni, 
& Borot, 2011). 
The MiniMed continuous glucose monitor was the precursor to Medtronic iPro2 
device which is being used in this study and was released in March of 2012. The validity 
of the MiniMed device to accurately assess glucose has been shown to be good (Wallace 
et al., 2006). A recent review pooled all of the studies that compared blood glucose 
values and hemoglobin A1c values to those obtained by the MiniMed device and found 
good correlations for blood glucose r = 0.73-0.92 and for hemoglobin A1c (HBA1c) r = 
0.53–0.59. The review also looked at controlled studies that used CGM devices to 
improve glucose control in diabetics and found a significant reduction in HBA1c. 
Furthermore, the authors stated that the use of these devices could lead to substantial 
reductions in morbidity and mortality associated with diabetes (Tavris & Shoaibi, 2004).  
CGM technology has shown great utility in helping diabetic patients detect periods of 
hyper- or hypoglycemia (Hay, Wilmshurst, & Fulcher, 2003; S. Praet et al., 2006). There 
has been some concern about the lag time between glucose levels in the blood compared 
to the interstitial space (Cengiz & Tamborlane, 2009; Riddell & Perkins, 2009). Most 
studies show that a 5-10 minute lag time in the change in blood glucose compared to 
interstitial glucose exists (Boyne, Silver, Kaplan, & Saudek, 2003). Due to greater 
interstitial space glucose utilization, CGM use during exercise exaggerates this lag 
(Riddell & Perkins, 2009). With these problems in mind all CGM devices account for this 
time lag with their built in algorithms, but measurement during exercise may still be 
problematic (Penfornis et al., 2011).  
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The recent application of CGM devices in exercise studies has opened up a new 
realm of possibilities for exercise physiologists to obtain a more complete picture of 
glucose control with a relatively non-invasive measurement. Recent studies using CGM 
before and after exercise interventions have shown promising results in its utility in 
exercise research (Cauza et al., 2005; Gillen et al., 2012; Little et al., 2011; Mikus, 
Oberlin, Libla, Boyle, & Thyfault, 2012). Also CGM may give an insightful picture of 
glucose control in subjects who have normal fasting glucose levels, but may be in the 
early phases of progression to IGT (Ma et al., 2011).  
Finally, the assessment of glycemic variability has shown importance in the 
prediction of CAD severity and diabetic complications (Monnier, Colette, & Owens, 
2008; Monnier & Colette, 2011; Su et al., 2011). Even more so than sustained 
hyperglycemia, high glycemic variability is associated with increases in oxidative stress 
which accounts for many of the diabetic complications due to advanced glycation end-
products in T2D (Monnier et al., 2008). CGM represents the most accurate means of 
assessing glycemic variability. Therefore, the use of continuous glucose monitoring in 
exercise and diabetes research is a valid and meaningful method of assessing glucose 
control in subjects anywhere on the spectrum from NGT to T2D.  
The Effect of Exercise on the Various Aspects of Glucose Control 
It has become quite clear that high levels of physical fitness as well as physical activity 
help to prevent the occurrence of IGT and T2D (Helmrich, Ragland, Leung, & 
Paffenbarger Jr, 1991; LaMonte, Blair, & Church, 2005). Data from the Aerobics Center 
Longitudinal Study showed that being in the lowest fitness quartile of a group of 8633 
men led to a 1.9 fold higher risk of developing IGT and a 3.7 fold higher risk of 
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developing T2D after 6 years of follow-up (Wei et al., 1999).  This protection from the 
onset and progression of T2D afforded by exercise is most likely due to a multitude of 
different effects encompassing all aspects of the pathophysiology of impaired glucose 
control discussed above (Booth et al., 2012). The following sections will focus on the 
improvements in the three main components of glucose control (β-cell function, hepatic 
insulin resistance, and peripheral insulin resistance) due to exercise. Each section will 
also include a discussion on the research conducted using HIT on each specific 
parameter.  
The Effect of Exercise on β-Cell Function. Only seven studies to date have been 
published on the effects of exercise on β-cell function in humans (Bloem & Chang, 2008; 
Dela, von Linstow, Mikines, & Galbo, 2004; S. Kahn et al., 1990; Krotkiewski et al., 
1985; Malin & Kirwan, 2012; Slentz et al., 2009; T. P. Solomon et al., 2010). The first 
study published in this area showed that 3 months of aerobic exercise in T2D patients 
lead to improvements in insulin secretion during an OGTT (Krotkiewski et al., 1985). 
Another early study used six months of intensive endurance exercise in 13 healthy older 
men and saw a 36% increase in insulin sensitivity. Interestingly, the authors stated that β-
cell function decreased because they observed a reduction in the acute phase insulin 
response (AIR) to the OGTT. The reduction in AIR was most likely caused by the 
improvement in insulin sensitivity and without the use of the disposition index to assess 
β-cell function we cannot be sure of the results (S. Kahn et al., 1990). A more recent 
study in healthy sedentary elderly men and women showed that 7 consecutive days of one 
hour per day of aerobic exercise led to a 29% improvement in the disposition index along 
with a 57% improvement in insulin sensitivity. Similar to the study above AIR 
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significantly decreased, but the use of the disposition index clearly shows that this 
decrease was likely due to the large increases in insulin sensitivity and β-cell function 
(Bloem & Chang, 2008). Another recent study showed that three months of five 
days/week of exercise at 75% of VO2max in T2D subjects led to improvements in β-cell 
function in the subjects who started out as moderate insulin secretors, but those that 
started out as low secretors did not improve at all. The findings suggest that there may be 
a point of no return in β-cell dysfunction (Dela et al., 2004). A study in 76 pre-diabetic 
adults used 12 weeks of 5 days/week aerobic exercise for 60 minutes at 85% of 
maximum heart rate and found improvements in β-cell function across all pre-diabetes 
subtypes (Malin & Kirwan, 2012). 
The only study in the literature to assess different doses and titrations of exercise 
for the improvement of β-cell function was the STRRIDE trial. 237 subjects were 
randomized into either the 1) high amount vigorous exercise group (equivalent to 20 
miles/week of jogging); 2) low-amount vigorous intensity group (equivalent of jogging 
12 mile/week); or 3) low-amount moderate intensity (equivalent of 12 miles/week of 
walking). The results from the intravenous glucose tolerance test showed that the 
moderate group had significantly greater improvements in insulin sensitivity (24 hours 
after the last session (Houmard et al., 2004) and 14 days after (Bajpeyi et al., 2009)) and 
β-cell function (Slentz et al., 2009), but no reduction in the AIR. The authors 
hypothesized that the moderate exercise led to more fat oxidation (evidenced by a greater 
decrease in triglycerides in the moderate group (Slentz et al., 2007)) than the vigorous 
exercise and this may have caused subsequent decreases in liver, adipocyte, and 
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pancreatic lipid accumulation leading to overall insulin sensitivity improvements as well 
as β-cell improvements (Slentz et al., 2009).  
Animal model studies may also shed some light on the effectiveness of exercise to 
improve β-cell function since the true gold standard technique in β-cell function can be 
used (β-cell mass, which cannot be utilized in live humans). Exercise training in diabetic 
rats leads to improvements in β-cell function and mass by 40-60% (Beaudry & Riddell, 
2012). A recent diabetic rat model study showed that exercise in diabetic rats led to 
increased insulin release, which was coupled with upregulation of insulin mRNA and 
insulin storage in the β-cell islets (Delghingaro-Augusto et al., 2012). This study provides 
a potential mechanism via the upregulation of insulin production and storage by the β-
cells in response to exercise training. Other potential mechanisms in the improvement of 
β-cell function via exercise include reductions in pancreatic lipotoxicity and glucotoxicity 
leading to improved insulin secretion (DeFronzo, 2009; T. P. J. Solomon et al., 2010).  
Therefore, the evidence that exercise improved β-cell function is limited, but the 
available studies suggest that exercise training has beneficial effects on β-cell function 
especially in diabetic subjects.  
The Effects of Exercise on Hepatic Glucose Secretion. As discussed above hepatic 
glucose secretion is a major determinant of blood glucose control. Insulin sensitivity of 
the liver dictates the ability of the liver to respond to a meal and/or current glucose levels 
(DeFronzo, 2009). Hepatic lipid accumulation may be a primary cause of reduced insulin 
sensitivity in the liver (Kotronen, Seppaelae-Lindroos, Bergholm, & Yki-Jaervinen, 
2008; Magkos, 2010; Ryysy et al., 2000; Seppälä-Lindroos et al., 2002). This buildup of 
lipids in the liver is most likely due to increased circulating FFAs released from expanded 
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visceral (Nielsen, Guo, Johnson, Hensrud, & Jensen, 2004) and subcutaneous (Horowitz, 
Coppack, & Klein, 2001) fat depots. When large amounts of lipids accumulate in the 
liver in the form of FFAs they are easily converted into glucose and then released into the 
blood stream. The extra glucose production combined with insulin signaling dysfunction 
that occurs with hepatic lipid accumulation and the inflammatory status of IGT and T2D 
leads to the inability of insulin to inhibit hepatic glucose release (Bergman et al., 2006; 
Kabir et al., 2005). Promising results in the ability of exercise alone (Johnson et al., 2009; 
Kirwan, Solomon, Wojta, Staten, & Holloszy, 2009; Shojaee-Moradie et al., 2007; 
Sullivan, Kirk, Mittendorfer, Patterson, & Klein, 2012) and exercise in combination with 
diet (Haus et al., 2010; Schäfer et al., 2007; T. P. J. Solomon et al., 2009; T. P. J. 
Solomon et al., 2010; Tamura et al., 2005; Thamer et al., 2012)  to reduce hepatic insulin 
resistance with or without reductions in hepatic fat have begun to surface.  
The most robust study to look at the effects of exercise alone on hepatic fat and 
hepatic insulin resistance used six weeks of aerobic exercise (n = 10) or a control 
condition (n = 7) in sedentary men. The aerobic exercise consisted of 3 days/week of 
aerobic exercise at 60-85% of VO2max for at least 20 minutes. Magnetic resonance 
specroscopy (MRS) was used to measure liver and skeletal muscle fat and a two-step 
hyperinsulinaemic-euglycaemic clamp was used to assess hepatic and peripheral insulin 
sensitivity. After the intervention there were significant reductions in fasting non-
esterified fatty acids, glycerol, and palmitate, but no reductions were seen in muscle or 
liver fat. The small n may account for the lack of significance in the liver fat reduction. 
Most importantly the exercise group showed improvements in both hepatic and 
peripheral insulin sensitivity measured 72 hours after the last exercise session (Shojaee-
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Moradie et al., 2007). The authors speculated that the improvement in hepatic insulin 
sensitivity may have been due to reductions in FFAs, reductions in visceral fat, and/or 
reductions in hepatic fat that were not detected due to the small subject number. Another 
exercise only study used 7 days of exercise training (30 min/day at 70% of VO2max) in 
obese type 2 diabetics. Hepatic and peripheral insulin sensitivity, assessed via the 
hyperinsulinemic-euglycemic clamp, were improved after the intervention (Winnick et 
al., 2008). The results of this study may be completely due to the acute effect of exercise 
since the clamp was done 24 hours after the last exercise bout and it has been shown that 
the effects of exercise on insulin sensitivity last at least 48 hours (Eriksson, Taimela, & 
Koivisto, 1997). The authors speculated that the improvements in hepatic insulin 
sensitivity may have been due to activation of adenosine monophosphate-activated 
protein kinase (AMPK) in the liver, which results in the inhibition of 
phosphoenolpyruvate carboxykinase and glucose-6-phosphatase and therefore inhibits 
gluconeogenesis. This hypothesis is backed by the evidence that exercise activates 
AMPK (Carlson & Winder, 1999). Two other exercise only studies that resulted in no 
weight loss showed decreases in hepatic fat using either four weeks of aerobic exercise in 
obese men (Johnson et al., 2009) or 16 weeks of aerobic exercise in obese adults with 
non-alcoholic fatty liver disease (Sullivan et al., 2012). Unfortunately neither of those 
studies measured hepatic insulin resistance. The four-week study did measure fasting 
glucose and insulin and reported no changes in HOMA-IR scores, but that is not the ideal 
method of assessing peripheral or hepatic insulin resistance (Shaibi, Davis, Weigensberg, 
& Goran, 2011).  
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Short-term (Tamura et al., 2005) and long-term (Haus et al., 2010; Schäfer et al., 
2007; T. P. J. Solomon et al., 2010; Thamer et al., 2012) exercise and diet interventions 
in obese subjects, subjects with IGT, NGT, and T2D have shown positive results in the 
reduction of liver fat and/or improvements in liver insulin sensitivity. An exemplary 
study used 12 weeks of aerobic exercise (1 hour/day, 5 days/week, at 85% of max heart 
rate) plus either a low-glycemic diet (n = 10) or a high glycemic diet (n = 12). 
Measurements were done via euglycemic-hyperinsulinemic clamp, oral glucose insulin 
and incretin reponses, dual-energy x-ray absorptiometry (DXA) and computed 
tomography (CT) scans. After the intervention both groups showed marked 
improvements in both peripheral (76%) and hepatic (27%) insulin sensitivity with no 
differences between groups (T. P. J. Solomon et al., 2010). Another study compared 
exercise alone to diet plus exercise and found improvements in hepatic insulin sensitivity 
in both treatments, but only the diet plus exercise group improved their insulin sensitivity 
response to infused FFAs (Haus et al., 2010).  
The only study comparing the effects of HIT to continuous exercise in the 
improvement in hepatic insulin resistance was a training study conducted with rats. After 
eight weeks of exercise in rats with metabolic syndrome there were increases in insulin 
receptor phosphorylation in the skeletal muscle and liver cells. The HIT showed to be 
more effective at improving insulin receptor phosphorylation in the skeletal muscle, but 
the effect was the same in both groups for the liver insulin receptors (Haram et al., 2009).  
A recent review of the literature on exercise and the reduction of hepatic fat stated 
that a 20-40% reduction in hepatic fat is typically observed after exercise interventions 
(Magkos, 2010). Since lipid accumulation in the liver is the most likely reason for 
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reduced hepatic insulin sensitivity it is likely that these improvements would be translated 
into improved hepatic responses to insulin. With the limited data available in the 
improvements in hepatic insulin sensitivity in response to exercise it is conceivable that 
exercise alone and very convincing that exercise with diet can reduce hepatic insulin 
resistance and hepatic fat. 
The Effects of Exercise on Peripheral Insulin Sensitivity. The first suggestion 
that exercise training may increase the muscle’s sensitivity to insulin came in 1972 with a 
simple cross-sectional study comparing insulin sensitivity in trained versus untrained men 
(Björntorp et al., 1972). This study was followed by multiple studies showing that trained 
individuals have a lower insulin response to an oral glucose challenge compared to 
untrained, but the glucose levels of the trained individuals still stays lower (Seals et al., 
1984). Next via use of the hyperinsulinemic-euglycemic clamp technique it was shown 
that trained people have a higher rate of insulin stimulated glucose disposal than 
untrained (Hollenbeck, Haskell, Rosenthal, & Reaven, 1985). During this time of early 
exercise and insulin resistance research there was some controversy over the question of 
the long vs. short term effects of exercise (Goodyear & Kahn, 1998). One study showed 
that after 10 days of inactivity the insulin response to a glucose load was the same in 
trained and untrained men (Heath et al., 1983). However, by use of the hyperinsulinemic-
euglycemic clamp it was shown that the maximal insulin-stimulated glucose disposal rate 
was higher even after 10 days of inactivity suggesting a sustained training effect on 
insulin responsiveness (King et al., 1988).  Therefore, it is now well accepted that 
exercise stimulates both acute effects and chronic adaptations in insulin sensitivity and 
responsiveness (Goodyear & Kahn, 1998). Whereas, insulin stimulated GLUT4 
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translocation is dependent on rapid phosphorylation of the insulin receptor, insulin 
receptor substrate-1/2 (IRS-1/2) on tyrosine residues, and the activation of 
phosphatidylinositol 3-kinase (PI3-K), exercise acutely stimulates GLUT4 translocation 
without use of any of these mechanisms. Acute exercise increases glucose uptake by 
stimulating the translocation of GLUT4 via the Ca2+ dependent activation of calmodulin, 
the AMP:ATP ratio driven activation of AMPK, and atypical protein kinase C activation 
all of which are insulin dependent pathways (Röckl, Witczak, & Goodyear, 2008).  
The adaptations to exercise training that induce increased insulin sensitivity and 
glucose disposal include: 1) muscle fiber type changes, 2) increases in mitochondrial 
activity and content, and 3) increases in GLUT4 protein expression. It is well known that 
endurance training elicits increases in mitochondrial content of skeletal muscle which are 
associated with, but not completely indicative of muscle fiber type. Type I fibers have 
more mitochondrial mass than type II and type IIa have greater mitochondrial mass than 
IIx and finally type IIb have the lowest mitochondrial mass. Muscle fiber typing done 
specifically on the myosin heavy chain isoforms shows that endurance training leads to 
fiber type switching from type IIb to IIx to IIa and even in rare cases a complete switch to 
type I (Pette & Staron, 2001). The more oxidative the fibers the more glucose disposal 
they perform. As muscle fiber type moves towards the more oxidative fibers they have 
higher GLUT4 expression and higher mitochondrial mass. Furthermore, independent of 
fiber type endurance training leads to increased expression of GLUT4. The effects of 
endurance training induce three very important adaptations in skeletal muscle that lead to 
greater insulin sensitivity and greater glucose disposal (Röckl et al., 2008).  
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Due to the large volume of studies published on the improvements in insulin 
sensitivity and exercise (Web of Science search for “Aerobic Exercise” AND “Insulin 
Sensitivity” yielded ~900 articles), the section below will be spent discussing large 
impactful studies looking at the effects of exercise on insulin sensitivity.  
A study of 1467 women with impaired glucose tolerance measured physical 
activity via questionnaire and insulin sensitivity via the frequently sampled intravenous 
glucose tolerance test. The authors showed that women who participated in vigorous 
exercise 5 days/week had insulin sensitivity that was 75% better than those who did no 
vigorous exercise at all. Even reporting vigorous exercise 1-3 times/month yielded a 22% 
increase in insulin sensitivity (Mayer-Davis et al., 1998). Results from the HERITAGE 
study including 316 women and 280 men showed an approximate 10 percent 
improvement in insulin sensitivity (assessed via intravenous glucose tolerance test) after 
20 weeks of three days/week of aerobic exercise (Boulé, Haddad, Kenny, Wells, & Sigal, 
2001). A large (n = 102), well-designed study evaluating the effectiveness of exercise on 
improvements in muscle oxidative capacity and insulin resistance showed that subjects of 
all ages (21-87 years) improved muscle markers of oxidative capacity, GLUT4 
expression, aerobic capacity, and visceral fat, but only the young (under 40 years) 
showed improvements in insulin sensitivity suggesting an age related effect (Short et al., 
2003).  
Another large intervention study evaluated the effectiveness of six-months of 
endurance training in 119 NGT and 47 IGT individuals for improving insulin sensitivity 
assessed via OGTT (Jenkins & Hagberg, 2011). Interestingly, the individuals who started 
out with NGT did not significantly improve in any glucose levels during the OGTT, but 
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did significantly reduce insulin and HOMA levels. The IGT subjects significantly 
reduced all variables during the OGTT and most of those improvements were greater 
than the NGT subjects. Although there was a significant improvement in insulin 
sensitivity the IGT subjects still did not attain the NGT levels at baseline. Therefore, 
subjects with IGT will most likely improve insulin sensitivity to a greater extent than 
NGT individuals in response to exercise training, but they may not become completely 
NGT even after long-term exercise training. Complete normalization of glucose tolerance 
has been seen in T2D subjects and IGT subjects in response to training of a much higher 
intensity (Holloszy, Schultz, Kusnierkiewicz, Hagberg, & Ehsani, 1986). Twelve months 
of exercise (5 days/week at ~90% of VO2max for 60 minutes each session) led to complete 
normalization of glucose tolerance in all IGT subjects and most T2D subjects. Therefore 
it may be that exercise of higher intensity and duration is necessary to completely restore 
glucose tolerance (Jenkins & Hagberg, 2011). Similarly, a study in 25 healthy older, 
inactive women used 3 randomly selected exercise prescriptions for nine-months. All 
three groups were matched for caloric expenditure and varied by intensity and duration 
(80%, 65%, and 50% VO2peak). Insulin sensitivity was measured via the euglycemic-
hyperinsulinemic clamp conducted 72 hours after the last exercise session. The higher 
intensity group showed significant improvements in both glucose utilization at the high-
insulin dose and insulin-stimulated suppression of adipose tissue lipolysis at the low-
insulin dose. These results suggest that long-term higher intensity exercise may be 
superior for improvements in both fat and muscle insulin sensitivity (DiPietro, Dziura, 
Yeckel, & Neufer, 2006).  
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The most robust study to date examining the effects of different exercise doses in 
the improvement of insulin sensitivity is the study already described in detail above 
known as the STRRIDE trial (Bajpeyi et al., 2009; Houmard et al., 2004). An intravenous 
glucose tolerance test was used to measure insulin action and calculate the insulin 
sensitivity index in 154 sedentary, overweight/obese subjects before and after six months 
of exercise training. All three exercise groups (high volume, moderate intensity; low 
volume, moderate intensity; and the low volume, high-intensity) improved insulin 
sensitivity, but the two groups that exercised for longer durations each day (low volume, 
moderate intensity and high volume, high-intensity) improved to a greater extent (85% 
improvement versus 40% improvement (Houmard et al., 2004). This same pattern was 
seen when insulin sensitivity was measured again 15 days after the cessation of exercise 
indicating that the effect of greater exercise time per session may elicit more sustainable 
changes (Bajpeyi et al., 2009).  
Many studies have shown improvements in insulin sensitivity with high and low 
intensity, volume, and duration of exercise therefore the findings of the STRRIDE trial 
are difficult to explain (Babraj et al., 2009; Kang et al., 1996; Larsen, Dela, Madsbad, & 
Galbo, 1999; S. F. Praet & van Loon, 2007; S. F. Praet & van Loon, 2009; Snowling & 
Hopkins, 2006). For example a study used 6 weeks of three days per week of sprint 
interval exercise which totaled 10 minutes per session and observed a 28% improvement 
in insulin sensitivity measured 3 days after the last exercise session (Metcalfe, Babraj, 
Fawkner, & Vollaard, 2011). Conversely, Larsen’s group in Denmark has used high and 
low intensity exercise in T2D patients and has observed improvements with both modes, 
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bringing them to a similar conclusion of the STRRIDE trial that total exercise time may 
be the most important factor (Larsen, Dela, Kjær, & Galbo, 1997; Larsen et al., 1999).  
The most comprehensive findings in the issue of exercise dose in improving 
insulin sensitivity may be found in a recent meta-analysis (Snowling & Hopkins, 2006). 
After pooling the results of 13 well-designed studies there was no clear effect of exercise 
intensity or time in the improvement of insulin sensitivity. The major difference in 
intensity related improvements in insulin sensitivity may not be found in moderate 
exercise versus vigorous, but possibly in HIT versus continuous (C. P. Earnest, 2008). 
Some recent, small, studies without comparison groups in T2D and healthy subjects show 
the drastic effects that HIT can have on insulin sensitivity in a short period of time or 
even after one bout of exercise (Babraj et al., 2009; Gillen et al., 2012; Hood, Little, 
Tarnopolsky, Myslik, & Gibala, 2011; Little et al., 2011; Metcalfe et al., 2011; Whyte, 
Gill, & Cathcart, 2010). Two weeks of 30 minutes of HIT per week led to a 369% 
improvement in GLUT4 protein content as well as improved 24-hour glucose control in 
T2D patients (Little et al., 2011). Similarly, two weeks of HIT led to significantly 
improved markers of muscle mitochondrial function, glucose transport, as well as insulin 
sensitivity in seven sedentary adults (Hood et al., 2011). A small RCT found that 15 
weeks of HIT versus steady state exercise led to significant reductions in fasting insulin 
only in the HIT group (E. Trapp et al., 2008). Therefore, there is much work to be done in 
the area of comparing the effects of HIT to continuous exercise for improvements in 
insulin sensitivity, but the early observations are suggesting that HIT may yield superior 
benefits.  
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The Effects of Exercise on Glycemic Control. After the review of literature 
above it is clear that exercise can improve the three major determinants of glucose 
control. The ability to control blood glucose levels in subjects with impaired glucose 
tolerance as well as individuals with T2D is of paramount importance in regards to 
delaying or halting the progression and onset of cardiovascular disease associated with 
poor glucose control (Selvin et al., 2004). The most common method of assessing long-
term blood glucose control is via measurement of glycosylated hemoglobin (HbA1c). A 
non-enzymatic reaction between glucose and hemoglobin in red blood cells leads to 
glycosylated hemoglobin. The higher the blood glucose has been over the past four weeks 
to three months then the higher percentage of hemoglobin will be glycosylated.  
Both aerobic and resistance exercise have been shown to improve HbA1c 
(Snowling & Hopkins, 2006). Many large scale clinical trials have been conducted 
evaluating the effects of exercise on the improvement of glucose control measured via 
HbA1c. Due to the large number of studies in this area multiple meta-analyses have been 
conducted that adequately pool the results of all studies. The first meta-analysis pooled 
the clinical trials published up until December of 2000. The authors included only studies 
in T2D that involved durations of 8 weeks or more. The authors located 12 aerobic 
exercise studies and two resistance exercise studies and found that overall the exercise 
interventions yielded a reduction in HbA1c of 0.66% (Boulé et al., 2001). The next meta-
analysis published five years later included 27 exercise studies that used multiple 
outcomes for glucose control improvement. Most relevant to this section was the HbA1c 
data which showed the following reductions in HbA1c%: -0.37 aerobic, -0.29 resistance, 
and -0.43 combined aerobic and resistance. The authors concluded that combined 
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strength and endurance training as well as higher intensity exercise (-0.29% greater 
improvement) may both lead to greater improvements in HbA1c (Snowling & Hopkins, 
2006). Another meta-analysis published in 2006 included 14 RCTs including 377 T2D 
patients. The authors found a -0.6% reduction in HbA1c that was associated with a -45.5 
cm2 reduction in visceral fat (Thomas, Elliott, & Naughton, 2006). Therefore, from these 
comprehensive reviews it is clear that exercise has a small but significant effect on 
glucose control assessed via HbA1c.  
Another relatively novel approach to assessing glucose control is via use of 
continuous glucose monitoring (CGM). Instead of obtaining average glucose values over 
weeks to months CGM gives glucose values every 1-15 minutes. A few studies have used 
CGM to monitor changes in glucose control after an intervention period. The first study 
published in this area used four months of strength or endurance training in 15 patients 
with T2D and conducted continuous glucose monitoring before and after the intervention 
(Cauza et al., 2005). The authors did not mention any steps taken to control food intake 
during the testing periods, which is a serious limitation to the study. Interestingly, the 
authors did not see a significant improvement in glucose control in the endurance training 
group but the strength training group improved significantly. A seven day aerobic 
exercise study in T2D patients used continuous glucose monitoring to assess glucose 
control before and during the last 3 days of the exercise intervention. The subjects 
significantly decreased maximum blood glucose, difference between minimum and 
maximum blood glucose, and the number of low excursions each day during the 
intervention period (Mikus et al., 2012). Results from this study must be taken in the light 
of the fact that the subjects were exercising while wearing the CGMs, therefore the 
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improvements in glucose control were due to the acute effects of exercise. Finally, a two-
week exercise study using HIT in T2D patients utilized CGM to assess glucose control. 
After only 6 sessions of exercise the subjects decreased their average 24-hour glucose 
values and the sum of the 3 hour postprandial glucose areas under the curve for each meal 
assessed by CGM 48-72 hours after their last exercise session (Little et al., 2011). 
Therefore, there are very limited exercise interventions using CGM as the method of 
assessing glucose control, but the studies conducted so far show encouraging results that 
align with the large body of evidence showing the exercise can improve glucose control 
in subjects with IGT or T2D. 
Section 3: Visceral Adipose Tissue 
Correlation between Visceral Adipose Tissue and Cardiometabolic Diseases 
The interest in abdominal fat first started in the early 1980s when Kissebah and 
colleagues (1982) published their landmark study showing that women with upper body 
obesity had a higher likelihood of having glucose/insulin disturbances than those with 
lower body obesity. A large epidemiological study of 15,532 obese women followed that 
report and showed that those with upper body obesity had a 10-fold increased risk of 
having T2D compared to those with lower body obesity (Hartz, Rupley, Kalkhoff, & 
Rimm, 1983). Another landmark study from Japan showed that even in non-obese men 
high levels of visceral adipose tissue (VAT) were predictive of CAD, hyperlipidemia, 
hyperglycemia, and hypertension (Nakamura et al., 1994). Many other large 
epidemiological studies confirmed these findings by showing that anthropometrically 
measured abdominal obesity is related to T2D, IGT, and CVD (J. P. Despres et al., 1990).  
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After the development of computed tomography (CT) for the quantification of 
VAT, multiple studies confirmed the findings of the earlier studies that only used 
anthropometric measurements. These findings clearly confirmed that the amount of VAT 
quantitatively measured by CT was inversely associated glucose tolerance (Després et al., 
1989; Fujioka, Matsuzawa, Tokunaga, & Tarui, 1987; Sparrow, Borkan, Gerzof, 
Wisniewski, & Silbert, 1986).  Since then many large studies have shown strong 
correlations between high levels of VAT and hyperlipidemia, hypertension, impaired 
vascular function, cardiovascular disease, IGT, and T2D (Arcaro et al., 1999; Bergman et 
al., 2006; J. P. Despres et al., 1990; Després et al., 1989; Després, 2007; Tchernof & 
Despres, 2013). 
Pathophysiology of Visceral Adipose Tissue 
The internal adipose tissue, adipose tissue that is not subcutaneous, includes the 
intrathoracic and intra-abdominopelvic regions. Intrathoracic adipose includes pericardial 
adipose tissue and is not part of what is considered VAT. Intra-abdominopelvic adipose 
includes intraperitoneal and extraperitoneal adipose. Intraperitoneal adipose tissue is 
made up of two regions: the omentum and mesentery. Extraperitoneal adipose tissue 
includes preperitoneal and retroperitoneal adipose tissues. Even though the intra- and 
extraperitoneal adipose tissues are not distinguished when VAT is measured only the 
intraperitoneal adipose tissue drains its circulation into the portal vein (Tchernof & 
Despres, 2013). The proximity of the adipose tissue to the portal vein is central to one of 
the main hypotheses of the pathophysiology of VAT (Bergman et al., 2006; Björntorp, 
1990).  
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The adipocytes found in the mesenteric and especially the omentum regions have 
been shown to have distinct morphologies (less organized and larger), metabolic 
activities, neurological innervations, and blood flow patterns that make them unique and 
potentially pathological compared to other sites of adipose tissue. Furthermore, it is clear 
that during times of adipose tissue expansion (weight gain) premenopausal women tend 
to store more lipids in their subcutaneous abdominal and leg regions through hyperplasia 
whereas men and postmenopausal women tend to expand their visceral adipose regions 
via hypertrophy (Tchernof & Despres, 2013). This gender difference in preferential lipid 
storage may in part explain the earlier onset of CVD for men compared to women.  
Adipocyte size is positively correlated with insulin resistance and T2D, partly 
because of a high correlation of cell size and lipoprotein lipase (LPL) activity leading to 
increased blood lipids (Tchernof & Despres, 2013; Weyer, Foley, Bogardus, Tataranni, & 
Pratley, 2000). Since adipocytes in the omental and mesenteric regions are typically 
larger the increased LPL activity of these cells is strongly linked to a higher release of 
FFAs which can be taken up by the liver through the portal circulation. Studies using a 
high fat feeding dog model have given molecular evidence for this hypothesis. Twelve 
weeks of a high fat diet in dogs led to increases in the visceral to subcutaneous ratio for 
mRNA expression of lipolytic enzymes (LPL and hormone sensitive lipase despite higher 
insulin levels) and lipid accumulation enzymes (sterol regulatory element-binding 
transcription factor-1) suggesting expansion of the VAT as well as high release of FFAs. 
Furthermore the authors found increased gluconeogenic enzymes (glucose-6-phosphate 
and phosphoenolpyruvate carboxykinase) and triglyceride content of the liver, suggesting 
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increased hepatic glucose production and release (even in the face of hyperinsulinemia) 
and hepatic fat accumulation (Kabir et al., 2005). 
Another pathological finding with larger adipocytes, especially in the abdominal 
region, is that they have been shown to be resistant to hyperplasia which leads to lipids 
spillover into surrounding organs including the liver, the heart, the pancreas, and muscle. 
This spillover leads to “ectopic fat” accumulation in these other organs which is highly 
linked to insulin resistance in each of those sites (Gray & Vidal-Puig, 2007; Unger, 2002; 
Virtue & Vidal-Puig, 2010). An elegant of example of this is shown by the use of PPAR-
γ agonists (thiazolidinediones; TZDs) which stimulate adipocyte hyperplasia and lead to 
the formation of small insulin sensitive adipocytes and have been shown to improve 
glucose tolerance (Giannini, Serio, & Galli, 2004). It has also been shown that visceral 
adipose tissue is highly resistant to the suppression of lipolysis compared to subcutaneous 
tissue. This resistance is likely to lead to a higher release of FFAs from visceral fat 
compared to subcutaneous fat, especially in pre-diabetic conditions where 
hyperinsulinemia may be present (Zierath et al., 1998). Studies have shown that a large 
proportion of splanchic FFA release ends up accumulating in the liver in obesity (Nielsen 
et al., 2004). Hepatic triacylglycerol content measured with proton spectroscopy is 
closely correlated with hepatic insulin sensitivity in type 2 diabetic patients (Ryysy et al., 
2000) and in non-diabetic men (Seppälä-Lindroos et al., 2002).  
Another hypothesis regarding the link between VAT and cardiometabolic disease 
deals with the release of cytokines and adipokines from visceral adipocytes as well as 
macrophages that have infiltrated the fat regions. Leptin and adiponectin are both 
adipokines that are known to be protective against cardiometabolic disease. Leptin is 
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involved in regulating food intake and energy expenditure. Leptin resistance may play a 
role in increasing adiposity and decreasing energy expenditure during obesigenic states. 
Adiponectin is another adipokine that has anti-inflammatory and insulin sensitizing 
properties. Visceral fat is known to release lower levels of leptin and adiponectin and has 
been shown to be inversely related to both of these adipokines. Furthermore, high levels 
of the pro-inflammatory cytokine IL-6 have been shown to be related to VAT 
accumulation which may lead to insulin resistance and atherogenesis (Tchernof & 
Despres, 2013). 
The potential mechanisms of visceral fat leading to cardiometabolic disease 
discussed above can be summarized into three main hypotheses: 1) The portal theory: 
stating that differences in metabolism and the proximity of VAT to the portal circulation 
lead to excessive accumulation of FFAs in the liver, contributing to abnormal liver 
metabolism resulting in: high levels of apolipoprotein B-containing lipoprotein 
production and release, increased liver glucose production and release, and reduced 
hepatic insulin sensitivity (Bergman et al., 2006; Björntorp, 1990). 2) The inflammatory 
profile of enlarged visceral adipocytes with infiltrated macrophages leads to low levels of 
protective cytokines (leptin and adiponectin) and  high levels of pro-inflammatory 
cytokines (IL-6, IL-1β) which contribute to systemic inflammation, insulin resistance, 
and possibly an inflammatory state of the liver leading to further degradation of liver 
metabolism (Donath & Shoelson, 2011). 3) The inability of subcutaneous fat to act as a 
the primary storage depot of excess caloric intake leads to excessive VAT accumulation 
as well as ectopic fat accumulation and lipotoxicity of the heart, liver, kidneys, pancreas, 
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and muscle which may lead to dysfunction of these organs and further insulin resistance 
(Tchernof & Despres, 2013).  
Use of the iDXA to Measure Visceral Adipose Tissue 
The gold standard method of quantifying visceral adipose tissue is via computed 
tomography (Tchernof & Despres, 2013). Magnetic resonance imaging and ultrasound 
are both also used as viable alternatives to CT scans. All three assessment tool mentioned 
above are expensive and labor intensive. There is a need to identify automated and 
accessible methods of quantifying VAT that do not induce radiation on the patient. 
Recent technological advances in the imaging quality and algorithms used in the newest 
version of the General Electric dual-energy x-ray absorptiometry (DXA) system (iDXA) 
allow for the quantification of visceral adipose tissue (Ergun & Rothney, 2012). The 
patented CoreScan software uses the region of the scan known as the android region to 
quantify VAT. The android region is about 10 cm in height and as wide as the individual. 
The android region is between the iliac crest and a line that is 20% of the distance from 
the iliac crest to the base of the mandible. Since the fat in this region consists of 
subcutaneous and visceral fat the software uses an algorithm consisting of the width of 
the subcutaneous fat as the far lateral regions of body where the thickness of the fat layer 
actually represent the thickness of the subcutaneous fat and the anterior-posterior 
thickness of the abdomen. The anterior-posterior thickness can be attained using the 
tissue attenuation image obtained by the iDXA. Finally, the subcutaneous fat is 
subtracted from the total fat to obtain VAT. The CoreScan algorithm was developed 
using paired iDXA and CT images from approximately 350 subjects with a wide range of 
BMI and age, located in three different sites (Ergun & Rothney, 2012).  
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The iDXA measurement of VAT was validated in two publications in the summer 
of 2012 (Kaul et al., 2012; Micklesfield, Goedecke, Punyanitya, Wilson, & Kelly, 2012). 
The first study compared CT and iDXA scans in 131 black and white South African 
women. The authors found good correlation (r = 0.93) and low error rates (SEE = 16 
cm2) when comparing the iDXA measurement of VAT to expertly read CT scans. This 
study also compared the iDXA scans to a clinical read of the CT scans and found that the 
iDXA performed just as well as the clinical read of the CT scans. The iDXA predicted 
86% of the variance (R2) in the expert read of the CT scan (Micklesfield et al., 2012). 
Another study conducted an iDXA and a CT scan in a sample of 124 men and women 
ranging in age from 18-90 years and BMI from 18.5-40 kg/m2. The R2 value between the 
VAT measured from the iDXA and the CT was 0.96. The iDXA bias calculated by using 
Bland-Altman plots was +56cm3 (Kaul et al., 2012). The authors of both studies 
concluded that the iDXA is a precise and valid tool in the measurement of VAT. Another 
study used 32 clinical subjects as well as phantom abdomen with measured quantities of 
VAT and conducted iDXA scans with 11 different iDXA devices. Each clinical subject 
completed 2 scans whereas the phantom abdomens underwent 5 scans each. The 
combined intra- and inter-device variation was less than 5% for both phantom and human 
scans (Rothney et al., 2013). Finally, the iDXA measurement of VAT in a sample of 939 
subjects was shown to correlate well with increased odds of hypertension, impaired 
fasting glucose, metabolic syndrome, and T2D (Rothney et al., 2012).  
No studies have been conducted that assess the ability of the iDXA system to 
accurately detect changes in VAT. The DXA has been shown to accurately detect small 
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changes in fat mass induced by addition of a 1 kg fat packet on individuals, but these 
measurements were for total body fat and not specific to the VAT (Warolin et al., 2012). 
The newly developed software used with the iDXA device seems to be a precise 
and valid assessment tool for the quantification of VAT. Unfortunately, all of the studies 
published so far on the use of the iDXA device to quantify VAT included GE employees 
with obvious conflicts of interest in the success of their product as authors on the papers. 
Therefore, no truly independent studies have been conducted on the iDXA’s ability to 
quantify VAT.  
The Effects of Exercise on Visceral Adipose Tissue 
Aerobic Exercise to Reduce VAT. The role of exercise in the reduction of 
visceral adipose tissue has been studied extensively with many different doses of exercise 
and in many different populations. Multiple studies have shown that reductions in VAT 
are significantly related to improvements in glucose tolerance and insulin sensitivity 
(Mourier et al., 1997; O'Leary et al., 2006). One of the first long-term studies to assess 
the ability of aerobic exercise to reduce VAT involved 14 months of exercise at 55% of 
VO2max, 4-5 days/week in premenopausal obese women (J. Despres et al., 1991). After the 
14 month intervention the women lost 4.6 kg of fat, improved VO2max, and significantly 
reduced VAT measured via CT. Therefore, the earliest study in this area indicated that 
aerobic exercise alone with total body fat loss reduces VAT. Many studies followed this 
early study so the rest of this section will be spent discussing the large impactful studies, 
meta-analyses, and the issues of exercise intensity and HIT for the reduction of VAT.  
A classic study evaluating many cardiovascular disease risk factors and their 
improvements with exercise training was the HERITAGE study.  This study included 557 
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men and women who exercised at 55-75% of VO2max 50 minutes/day, 3 days/week for 
20 weeks. CT scans were conducted pre and post and there was a significant reduction in 
VAT (77.9 to 73.3 cm2). The study showed that men reduced VAT by 7% whereas 
women only reduced VAT by 4.5% (Wilmore et al., 1999). Another large scale RCT 
including 173 overweight and obese postmenopausal women assessed visceral fat with 
CT scan before and after 12 months of aerobic exercise (5 days/week of moderate 
intensity exercise 45 minutes each session) or a control condition. After the intervention 
the exercise group significantly decreased VAT by 8.6 g/cm2 and the control group 
increased by .1 g/cm2 (Irwin et al., 2003). A more recent large scale RCT involved ~100 
men and 100 women in 12 months of aerobic exercise or control. The exercise consisted 
of 3 days/week supervised and 3 days/week home-based moderate to vigorous activity for 
60 minutes each session. Subjects in the exercise group lost weight, but even though the 
VAT seemed to go down the reduction was not significant (McTiernan et al., 2007).  
A very comprehensive meta-analysis published in 2006 found 10 RCTs that used 
advanced imaging techniques to measure VAT before and after an aerobic exercise 
intervention. Seven of the 10 RCTs showed reductions in VAT compared to the controls 
(Kay & Singh, 2006). A very recent meta-analysis limited their inclusion of studies to 
subjects who were overweight or obese, performed aerobic exercise, measured VAT with 
MRI or CT. The authors found 15 RCTs that met their inclusion criteria. The pooled data 
showed that in as little as 12 weeks a reduction of 30-40 cm2 in VAT is likely (Vissers et 
al., 2013). Therefore, the results from pooled data and meta-analytic techniques show a 
strong probability that exercise without diet can lower VAT in overweight and obese 
individuals.  
64 
Exercise Intensity and HIT. A systematic review attempted to calculate the 
exercise dose relationship for the reduction of VAT. Using nine RCTs and seven non-
randomized studies the authors concluded that exercise volume and not intensity was the 
most important variable in reduction of VAT (Ohkawara et al., 2007). Conversely, both 
meta-analyses discussed above stated that there were not enough studies directly 
comparing exercise intensities to draw conclusions about the ideal exercise intensity to 
reduce VAT (Kay & Singh, 2006; Vissers et al., 2013). 
Multiple studies have not detected differences in exercise intensity in the 
reduction of VAT (Cho et al., 2011; Gutin et al., 2002; Slentz et al., 2005). The 
STRRIDE trial (previously described in detail) evaluated the effects of different doses of 
exercise on the reduction in VAT. The study randomized 175 men and women with 
dyslipidemia to control or exercise at three different doses. Interestingly, the only group 
that lost a significant amount of visceral fat was the group that did high-intensity exercise 
for a long duration (equivalent of jogging 20 miles/week). The moderate intensity low 
volume and the high-intensity high volume groups did not lose VAT, suggesting that 
exercise volume and not intensity is the key factor in VAT reduction (Slentz et al., 2005). 
Unfortunately the STRRRIDE trial did not include a high volume moderate intensity 
group to truly evaluate the effects of differing intensities on VAT reduction. Similarly 
another RCT with 45 Korean women showed no difference in VAT reduction between 
low (40-50%VO2max) and high (70-75% VO2max) intensity exercise for 12 weeks, but both 
group significantly reduced VAT (Cho et al., 2011).  
Conversely, a few studies have shown that exercise at a vigorous intensity is 
superior to moderate exercise in reducing VAT (Coker et al., 2009; Irving et al., 2008; E. 
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Trapp et al., 2008). An RCT in obese women with the metabolic syndrome involved 16 
weeks of exercise (5 days/week) above (high-intensity group) or below (low intensity 
group) the lactate threshold. Interestingly, only the women in the high-intensity group 
significantly reduced VAT, suggesting that intensity of exercise may play a role in the 
reduction of VAT (Irving et al., 2008). Similarly, a small comparison randomized elderly 
overweight adults to either moderate (50% VO2max) or high (75% of VO2max) intensity 
exercise. After the 12-week intervention VAT the high-intensity group reduced VAT by 
39 cm2 and the moderate and control groups did not change (Coker et al., 2009). Finally, 
another RCT randomized 45 young normal weight women to either control, steady state 
exercise at 60% of VO2max, or high-intensity interval training 3 days/week for 15 weeks. 
Abdominal fat percentage was measured via DXA, therefore true VAT assessment was 
not conducted. Intriguingly the HIT group reduced abdominal fat significantly more than 
the other two groups (E. Trapp et al., 2008). This is the only study found comparing HIT 
to continuous exercise in the reduction of VAT. 
Mechanisms. Even though weight loss via diet without exercise has been shown 
to reduce VAT (Nicklas et al., 2009) the physiological effects of exercise may play a key 
role in the reduction of VAT. For example one study randomized 33 obese 
postmenopausal women with T2D into a diet only, exercise only, or a diet plus exercise 
group for 14 weeks. Percent body fat was reduced with all three interventions, but only 
the exercise groups showed significant reductions in VAT (Giannopoulou et al., 2005). 
An interesting physiological difference between fat cells in differing regions of the body 
could partially explain these differences. Studies conducted in the late 1980s to the early 
1990s by Peter Arner and colleagues (Arner, Kriegholm, Engfeldt, & Bolinder, 1990; 
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Arner, 1995; Wahrenberg, Lönnqvist, & Arner, 1989) measured the lipolytic activity of 
various adipose regions under the stimulation of various chemicals. Lipolytic activity can 
be measured in vivo via insertion of a microdialysis catheter which simultaneously infuse 
stimulatory chemicals (catecholamines) and measure glycerol release. This allowed the 
authors to discovery that the regulation of lipolysis during exercise occurs via 
catecholamine release (Arner et al., 1990). This technique limits the measurements to be 
of subcutaneous fat only, due to the location of visceral fat. Conversely, these authors 
also measured lipolytic activity in vitro after adipose tissue samples were removed from 
subjects (Wahrenberg et al., 1989). These studies showed that in subcutaneous adipose 
tissue the abdominal adipocytes are 10-20 times more sensitive to catecholamines via 
stimulating lipolysis compared to gluteal adipocytes (Wahrenberg et al., 1989).  
Shortly after these studies were conducted another group obtained visceral 
(omental) and subcutaneous (abdominal and gluteal) adipose tissue samples from subjects 
undergoing abdominal surgery. The researchers stimulated the cells via epinephrine and 
observed a 500% greater lipolysis in occur in the VAT cells compared to the 
subcutaneous cells. Furthermore, the omental cells were resistant to the normal 
antilipolytic effects of insulin (Richelsen, Pedersen, Møller-Pedersen, & Bak, 1991). 
Together these findings not only give credence to the portal theory in the high levels of 
FFAs released from VAT cells, but also show that VAT cells may be more responsive to 
the outpouring of catecholamines induced by exercise.  
Therefore, the likely mechanism of exercise reducing visceral fat even in the 
absence of weight loss is the high sensitivity of VAT cells to catecholamines. 
Catecholamines are released during exercise of all intensities and could stimulate 
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lipolysis to occur in the VAT cells, therefore reducing VAT. This same theory gives 
credence for an intensity dependent effect of exercise in the reduction of VAT. As 
exercise intensity increases, catecholamine release increases in a proportional manner 
(Pritzlaff et al., 1999; Pritzlaff et al., 2000). High-intensity interval training has recently 
been shown to acutely elevate catecholamines as well as glycerol levels in the blood 
suggesting that acute HIT leads to lipolysis (E. G. Trapp, Chisholm, & Boutcher, 2007). 
Furthermore it has been shown that more fat oxidation occurs after vigorous intensity 
exercise compared to moderate or light (Pritzlaff et al., 2000).  
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Chapter 3 
METHODOLOGY AND DATA ANALYSIS 
Participants 
We enrolled 22 healthy, obese (BMI ≥ 30) individuals between 18-45 years of age 
(men) and 18-55 (women). This age range was chosen based on the risk stratification 
guidelines published by the American College of Sports Medicine (Gordon, 2009). 
Subjects were screened by completion of the Physical Activity Readiness Questionnaire 
(PAR-Q) and excluded by any “yes” answers.  
Using change in glucose AUC from pre- to post-intervention (∆AUC) as the 
primary outcome measure, sample size was calculated to detect a 5% difference between 
groups for ∆AUC.  This seems reasonable based on previously published data (Little et 
al., 2011).  We planned for a 15% dropout rate and enrolled 11 subjects in each group 
which would have provided 90% power at a 0.05 α level of significance (two-sided).  
Based on these parameters, the recruitment goal was 11 subjects per group.  Only 9 
subjects per group completed the study and this gave us ~83% power to detect a 5% 
group difference in ∆AUC.  
Participant Screening 
After completing telephone or email screening all subjects visited the laboratory 
for a one-hour screening visit. During this visit subjects read and signed the informed 
consent form, filled out the PAR-Q, and discussed the details of the study with one of the 
investigators. Next we performed a brachial artery ultrasound in order to verify that a 
suitable acoustic window was present. Finally, each subject had their height and weight 
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measured to verify a BMI of 30 kg/m2 or above and rode a stationary bicycle for 5 
minutes to ensure this mode of exercise was suitable.  
Exercise Training 
All subjects completed three supervised exercise sessions per week for eight 
weeks for a total of 24 exercise sessions. Subjects were randomized to either HIT or 
continuous training (CONT) upon enrollment in the study. All exercise was conducted on 
cycle ergometers and the maximum heart rate achieved during either phase of the 
maximal exercise test (ramp or verification, at baseline and at four weeks) was used for 
exercise intensity prescription. Heart rate was continuously monitored by Polar heart rate 
monitors and recorded by research technicians. Each HIT training session consisted of a 
5-minute warm up at 50-60% of HRpeak followed by 10 one-minute intervals at 90-95% of 
HRpeak separated by 1 minute of cycling at a low intensity (~25-50 W), followed by a five 
minute cool down at 50-60% of HRpeak. Each CONT training session consisted of a 5-
minute warm up at 50-60% of HRpeak followed by 30-minutes of exercise at 70-75% of 
HRpeak, followed by a five minute cool down at 50-60% of HRpeak. Each session lasted 40 
minutes for the CONT group and 29 minutes for the HIT group. 
Testing Overview 
Baseline testing was conducted after abstaining from vigorous exercise and 
vitamins for 48 hours as well as alcohol and caffeine for 24 hours. The FMD at four 
weeks was ~48-72 hours after their last exercise session. Eight week testing was 
conducted with the 24 hour monitoring occurring ~48 after the last exercise session and 
the FMD and maximal exercise test occurring ~72 hours after the last exercise session. 
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 Day 1: For both the pre- and post-intervention testing subjects arrived at the 
laboratory in the afternoon at least two-hours after their last meal. At this time the 
continuous glucose monitor was inserted. Next, we went through detailed instructions on 
how to use and care for the CGM. Over the next day subjects ate controlled meals 
provided by the research team. Breakfast and lunch were given to the participants to take 
with them, dinner was provided via gift card to a local sandwich restaurant, and snacks 
were provided (See Appendix 2 for detailed dietary information). The CGM was inserted 
the day before the 24 hour monitoring period to ensure device initialization was complete 
by the next morning.  Subjects were asked to record the exact time and quantity eaten of 
each food item so that precise timing and content matching could be performed for the 
pre- and post-testing.  
Day 2: After the 24 hour monitoring and controlled diet period subjects returned 
to the laboratory the next morning after at least a 10 hour fast. During this visit we 
removed the CGM, took anthropometric measurements, performed the brachial artery 
FMD, Dual-energy X-ray Absorptiometry (DXA), and the maximal exercise test.  
Anthropometrics and Blood Pressure 
Height was assessed on a standing wall mounted stadiometer (SECA, 
Birmingham, United Kingdom). We ensured that subjects removed shoes and had their 
heels against the wall during the height measurement. Height was only measured at 
baseline. Weight was measured at baseline, 4 weeks, and 8 weeks while fasting in the 
morning with minimal clothing and all jewelry removed on an electronic scale that was 
calibrated daily (Cosmed, Rome, Italy). Abdominal circumference, sagittal diameter, and 
blood pressure were all assessed at baseline and 8 weeks in the morning while subjects 
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were fasting. Abdominal circumference was measured with subjects standing, at the level 
of the umbilicus using a standard Gulick tape measure. Sagittal diameter was measured 
using Holtain-Kahn calipers (Holtain, Crymych, United Kingdom) at the level of the 
superior iliac crests while subjects were standing. All anthropometric measurements were 
taken by the same researcher on all subjects.  Blood pressure was assessed after 20 
minutes of quiet rest in a dimly lit room using a Dinamap Pro series automated blood 
pressure monitor (GE, Helsinki, Finland). Two blood pressure measurements were taken 
with 5 minutes between the measurements.  
Maximal Exercise Test 
All subjects performed a ramp style maximal exercise test on a cycle ergometer at 
baseline, after four weeks of exercise, and after the 8-week intervention. Subjects were 
equipped with a mask attached to a hose, and Polar heart rate monitor for the metabolic 
measurement device (Parvo Truemax 2400TM, Parvomedics, Sandy, Utah) to measure 
ventilation and respiratory gas exchange data and heart rate continuously. The Parvo 
Truemax 2400TM has shown high validity and reliability (Bassett et al., 2001). We 
performed the standard three point calibration before each test. After collecting resting 
data for 2 minutes, subjects pedaled on a stationary cycle ergometer at a cadence of their 
choice at 50 watts (males) or 25 watts (females) for 5 minutes for the warm-up phase. 
After the warm-up phase, load increased continuously by 30 watts/min every minute 
(males) or 15 watts/min every minute (females) until the subject could not continue. 
Verbal encouragement was given to all subjects throughout the entire test.  The average 
of the two highest consecutive 15 second oxygen uptake averages during the test was 
taken as the peak VO2.  In order to verify attainment of VO2max, after a 5 to 10-minute 
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cool down period, in which subjects pedaled at the warm up work load, each subject 
performed an all-out test on the cycle ergometer at a constant-load of 100% of the peak 
load reached during the incremental exercise test.  Oxygen uptake was monitored as in 
the incremental exercise test, and the highest VO2peak was recorded as described above. If 
a subject achieved a higher heart rate or VO2 during the verification phase the verification 
results were used as the “peak” value for that test.  
Continuous Glucose Monitoring 
Continuous glucose monitoring was conducted by a Medtronic iPro2 continuous 
glucose monitor (CGM; Medtronic, Northridge, CA) both pre- and post-intervention. 
This device has been shown to correlated well with blood glucose (r = 0.73-0.92 ) (Tavris 
& Shoaibi, 2004). Furthermore, 97% of sensor readings have been shown to fall within 
the clinically acceptable zone for accuracy (Sachedina & Pickup, 2003). Subjects had a 
small micro-dialysis catheter inserted subcutaneously in their abdomen, via a spring 
loaded insertion device, to continuously monitor blood glucose levels. After insertion the 
glucose sensor was given 15 minutes to hydrate before the iPro2 recorder was connected. 
After the iPro2 was connected the device is covered with an adhesive, transparent 
dressing (Tegaderm, 3M) to hold the device in place and to protect the device from 
moisture. Subjects were instructed on how to use and care for the device and the catheter 
insertion site. Subjects were asked to keep the monitor in place until their return to the 
laboratory after the 24-hour monitoring period. CGM devices were calibrated using a 
standard glucometer (One-Touch, Ultra 2, Lifescan, Inc., Milpitas, California) 4 times 
throughout each 24-hour period (one hour after insertion, three hours after insertion, 
before each meal and before bed time). This calibration was conducted by the participants 
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using a standard finger prick. Subjects were asked to record their glucose values and time 
of each reading in the provided glucose log. The dietary and the glucose logs are then 
inputted upon uploading the CGM data. 
Brachial Artery Ultrasound 
Flow-mediated dilation (FMD) was measured with a Terason t3000 high 
resolution ultrasound machine (Terason Ultrasound, Burlington, MA) with a 10-MHz 
multi-frequency linear array probe. We followed the criteria set forth by the Brachial 
Artery Reactivity Task Force and the latest guidelines (Corretti et al., 2002; D. H. J. 
Thijssen et al., 2010). Participants were asked to lie quietly in a dimly lit room for 20 
minutes on a vascular imaging table before a sonographer (who has performed this 
procedure approximately 400 times) obtained baseline images for 60 seconds from the 
participant’s left arm. After the baseline images were completed the sonographer inflated 
a blood pressure cuff on the participants forearm to a pressure of 250 mmHg for five 
minutes. Sixty seconds prior to cuff release the sonographer began recording the image to 
ensure that a full one-minute baseline image was captured during occlusion. After five 
minutes of occlusion, cuff deflation occurred while the sonographer continued to record 
images for the next five minutes. In order to minimize error between the three 
measurement periods and so that exact matching of settings and conditions could be 
ensured the distance of the probe from the medial epicondyle of the humerus was 
measured and all ultrasound settings were noted in the subject’s file. Images were 
analyzed using a previously validated, brachial artery edge-detection software (Woodman 
et al., 2001) to detect baseline and peak diameter and blood flow velocity as well as the 
percent difference between the two diameters (FMD). We analyzed 20 of our FMD 
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videos two separate times in a blinded fashion to evaluate the reproducibility of our 
laboratory analysis of the FMD videos. Intra-class correlation coefficients were 
calculated using Cronbach’s alpha. Coefficients of variation were calculated by dividing 
the standard deviation of the duplicate measurements by the mean of the duplicate 
measurements then multiplying by 100 to obtain a percent. Cronbach alpha values 
between our duplicate measurements were 0.998, 0.998, and 0.997 for baseline diameter, 
peak diameter, and FMD%, respectively. The CV values were 0.44%, 0.41%, and 6.05% 
for baseline diameter, peak diameter, and FMD%, respectively. Therefore, we have 
demonstrated that the reproducibility of the FMD outcomes is high in our laboratory. 
Female subjects completed the ultrasound measurements during days 1-7 of the 
follicular phase of their menstrual cycle (immediately after menstruation begins) for each 
measurement period. Female subjects were asked to notify the investigators when they 
began menstruation at each of the three measurement points in order to schedule their 
testing visits during the follicular phase. The timing of this visit is important due to the 
large variation in FMD measurements caused by the menstrual cycle (D. H. J. Thijssen et 
al., 2010).  
Dual-energy X-ray Absorptiometry 
Dual-energy X-Ray Absorptiometry (DXA) was used to determine percent body 
fat, regional fat distributions, and visceral fat. The use of the new iDXA to quantify 
visceral fat has recently shown excellent validity by correlating very well with the gold 
standard (computed tomography) for visceral adipose tissue assessment (Kaul et al., 
2012; Micklesfield et al., 2012). Subjects lied face up in the DXA bed for 7-12 minutes 
while the DXA arm passed over the entire body. Females conducted a urine pregnancy 
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test in our laboratory (negative test was required before DXA could take place) prior to 
each DXA measurement. All DXA scans were performed by a certified radiology 
technician. 
Activity Monitoring 
In order to assess if subjects changed their overall physical activity level in 
response to the exercise interventions we used the Actigraph GT3x+ tri-axial 
accelerometer (Actigraph, Pensacola, FL). We used the device to measure both physical 
activity and sleep. The actigraph was given to each participant to be worn for a total of 
three weeks; baseline (a 7 day period within one month prior to the training), week 5, and 
week 8 of the training protocol. Participants were given an elasticized waist band to wear 
on the hip during the day and wristband to fix to the wrist at night and instructed on how 
to properly place the device during these times. Participants also completed a daily 
accelerometer/sleep log that captured information about their physical activity and sleep 
(e.g., bed time, wake time, time not worn, exercise bouts). The Actigraph sampling rate 
was set to 60 Hz during data collection periods. We defined a valid day as wear time of 
10 hours or more. Periods of at least 60 minutes with consecutive zero counts were 
considered non-wear time. We used the Freedson 1998 cut-points for identifying and 
quantify time spent in sedentary, light, lifestyle, moderate, vigorous, and very vigorous 
intensity activity zones (Freedson, Melanson, & Sirard, 1998). The cut points are as 
follows: Sedentary: 0 – 99 counter/minute (CPM), Light: 100 – 759 CPM, Lifestyle: 760 
– 1951 CPM, Moderate: 1952 – 5724 CPM, Vigorous: 5725 – 9498 CPM, Very 
Vigorous: 9499 - ∞ CPM. 
 
76 
Data Analysis 
Descriptive statistics (Means, SD) for the study participants were calculated 
across gender and intervention groups (i.e., HIT and CONT). Two-way ANOVA was 
used to test baseline mean differences between groups and gender. The Shapiro-Wilk 
tests were used to check normality assumptions for all outcome measures.  Two-way 
repeated measures ANOVA (RMANOVA) was used to test mean differences for each 
outcome measure across group, time, and group x time interaction factors. Time and 
group were used as the fixed factors. The sphericity assumption was justified using the 
Greenhouse-Geisser Epsilon (ε) test. If the sphericity assumption was violated, the 
adjusted critical F value (multiplied ε by the degrees of freedom) was used to test the 
research hypotheses.  The Bonferroni post-hoc tests were also used to detect mean 
differences for groups and times, respectively, when appropriate.  Area under the curve 
analyses were conducted with the CGM data using the trapezoidal method. Physical 
activity enjoyment scales and baseline data were checked for group differences with 
independent samples t-tests. Levene’s test for equality of variance was used for each t-
test and adjusted P values were used if necessary. Pearson correlations were used to 
investigate the relationships between the changes (delta values) in outcome variables.  
For the brachial artery ultrasound data, we utilized an allometric scaling technique 
recently described (Atkinson, Batterham, Thijssen, & Green, 2013) that accounts for the 
effect that baseline diameter has on FMD %. The scaling was conducted by 
transformation of both the baseline and peak diameters for pre- and post-intervention via 
the natural log function, then calculating the difference between peak diameter and 
baseline diameter. See equation below:  
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ln(Peak Diameter) – ln(Baseline Diameter) = ln Diameter Difference 
Next, we used linear mixed models with ln Diameter Difference as the dependent 
variable, group and time as the fixed factors, time as a repeated factor, and ln(baseline 
diameter) as a covariate to yield adjusted diameter change (from baseline to peak) values 
for each group at each time point. Finally, the adjusted changes in diameters were back 
transformed into FMD % values. All p-values were two-tailed, and values of less than 
0.05 were considered to indicate statistical significance. All statistical procedures were 
performed by using SPSS software (IBM, Armonk, NY).   
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Chapter 4 
RESULTS 
Subjects 
Twenty-one adults were enrolled in the study and 17 completed all the 
requirements of the study. Of those who completed the study, there were 4 males and 4 
females in the CONT group and 5 males and 4 females in the HIT group. As shown in 
Table 1 there were no statistical differences between groups in any variable at baseline.. 
Adherence to the exercise program by the 17 completers was 100%. All 17 completers 
attended all 24 exercise sessions and all testing visits over a period of nine to ten weeks. 
The Shapiro-Wilk tests justified normality assumptions in all main outcome variables. 
There was no statistical difference for physical activity enjoyment scale between HIT and 
CONT groups (CONT: 82 ± 22, HIT: 88 ± 19; P = 0.540). 
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Table 1: Baseline descriptive characteristics for the completers in each group 
split by gender. Values represent mean ± standard deviation. 
 Continuous High-Intensity 
Males 
(N=4) 
Females 
(N=4) 
Males 
(N=5) 
Females 
(N=4) 
Age (years) 
35  
±  
5.8 
33  
±  
10.4 
32.8  
±  
9.3 
39  
±  
8.1 
Height (cm) 
174.5  
±  
9.61 
164.45  
±  
3.51 
180.8  
±  
3.35 
162.93  
±  
10.22 
Weight (Kg) 
104.73  
±  
14.16 
93.77  
±  
5.29 
127.58  
±  
25.23 
94.16  
±  
14.48 
BMI (kg/m2) 
34.5  
±  
4.8 
34.7  
±  
1.9 
39.1  
±  
8.1 
35.3  
±  
2.0 
Body Fat 
(%) 
41.7  
±  
8.71 
51.05  
±  
1.81 
42.64  
±  
5 
49.35  
±  
2.82 
** Height and weight were significantly higher in the males compared to the 
females. Body fat was significantly higher in the females compared to the 
males. 
 
Body Composition and Anthropometrics 
 There were significant reductions in abdominal circumference (1.8%, P < 0.001), 
sagittal diameter (2.6%, P = 0.015), body fat % (1.3%, P = 0.025), leg fat % (2.1%, P = 
0.009), and gynoid fat % (2.4%, P < 0.001) from pre to post with all subjects combined. 
The sagittal diameter was not measured on two subjects in the HIT group because they 
were out of the range of measurement for the calipers used in the study. There was also a 
non-significant trend for an increase in lean mass from pre to post with all subjects 
together (P = 0.071). There were no significant changes in weight, BMI, fat mass, arm 
fat, trunk fat, gynoid fat, android fat, or visceral fat (all P values were > 0.05). There 
were no statistical differences between HIT and CONT groups for all outcome measures 
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(all P values were > 0.05). There were non-significant trends for greater reductions in 
gynoid fat (P = 0.099) and visceral fat mass (P = 0.162) in the HIT group compared to 
the CONT (See Table 2).  
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Table 2: Descriptive and anthropometric data Pre- and Post-intervention. Values 
represent: Mean ± Standard deviation 
 
All  
(N=17) 
Pre                Post 
Continuous  
(N=8) 
Pre                Post 
High-intensity 
Interval  
(N=9) 
Pre                Post 
Weight (kg) 
106.38  
±  
21.44 
106.44 
± 
21.14 
99.25 
± 
11.50 
99.48 
± 
12.15 
112.73 
± 
26.59 
112.63 
± 
25.96 
Abdominal 
Circumference 
(cm) 
115.7 
 ±  
14.6 
113.6*  
±  
14.8 
113.8 
± 
8.7 
112.8 
± 
8.3 
117.4  
± 
18.8 
114.7 
± 
19.4 
Sagittal 
Diameter 
(cm)+ 
30.2  
± 
 2.4 
29.4*  
± 
2.8 
30.6 
± 
2.9 
29.8 
± 
3.6 
29.8 
± 
1.8 
28.9 
± 
1.4 
Body Fat (%) 
46.0  
±  
6.3 
45.4*  
±  
6.6 
46.4 
± 
7.7 
46.0 
± 
7.7 
45.6 
± 
5.3 
44.8 
± 
5.8 
Body Fat (kg) 
48.82  
±  
11.77 
48.23  
±  
11.74 
45.81 
± 
8.51 
45.57 
± 
8.58 
51.49 
± 
14.02 
50.60 
± 
14.06 
Lean (kg) 
57.57  
±  
13.53 
58.21 
± 
13.55 
53.43 
± 
11.35 
53.91 
± 
11.62 
61.23 
± 
14.88 
62.03 
± 
14.64 
Arm Fat (%) 
40.7  
±  
8.5 
40.4  
±  
8.8 
41.6 
± 
9.5 
41.4 
± 
9.9 
39.9 
± 
8.0 
39.4 
± 
8.2 
Leg Fat (%) 
42.6  
±  
7.5 
41.7*  
±  
7.7 
43.6 
± 
7.2 
43.0 
± 
7.2 
41.7 
± 
8.2 
40.6 
± 
8.4 
Trunk Fat 
(%) 
51.0 
± 
6.7 
50.4 
 ±  
6.9 
51.1 
± 
8.6 
50.8 
± 
8.6 
50.9 
± 
5.0 
50.0 
± 
5.5 
Android Fat 
(%) 
55.0 
 ± 
 6.9 
54.5 
±  
7.2 
55.2 
± 
8.9 
55.0 
± 
9.0 
54.8 
± 
5.1 
54.0 
± 
5.7 
Gynoid Fat 
(%) 
45.3  
±  
7.0 
44.2*  
±  
7.1 
46.1 
± 
7.5 
45.5 
± 
7.6 
44.6 
± 
7.0 
43.1 
± 
6.9 
Visceral Fat 
(cm3) 
2118  
 ± 
1172 
2131  
±  
1171 
1762 
± 
953 
1797 
± 
944 
2434 
± 
1309 
2428 
± 
1323 
*Significant change from pre to post all subjects together; +N=15 for this variable 
only. 
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Blood Pressure and Maximal Oxygen Uptake 
 As shown in Table 3, there were no significant changes in resting systolic or 
diastolic blood pressure by time, group, or group x time interaction factors. One subject 
in the HIT group did not perform the post VO2max test. VO2max significantly increased 
from baseline to 4 weeks (2.21 ± 0.57 to 2.44 ± 0.72, P = 0.023) and again from 4 weeks 
to 8 weeks (2.44 ± 0.72 to 2.56 ± 0.75, P = 0.008) with all subjects combined. There were 
no statistical differences in VO2max between the HIT and CONT groups (P = 0.870) or 
group x time interaction (P = 0.477). Similar results were seen with VO2max expressed 
relative to body weight (See Table 3 and Figure 1).  
Table 3: Resting blood pressure, continuous glucose monitoring data, and 
maximal oxygen uptake. Values represent mean ± Standard deviation. 
 
All  
(N=17) 
 
Pre                Post 
Continuous  
(N=8) 
 
Pre                Post 
High-Intensity 
Interval  
(N=9) 
Pre                Post 
Systolic Blood 
Pressure (mmHg) 
130  
±  
10 
129 
 ± 
 10 
128  
±  
6 
128 
 ± 
 7 
132  
±  
13 
129  
±  
12 
Diastolic Blood 
Pressure (mmHg) 
82  
±  
9 
86  
±  
10 
80  
±  
5 
84  
±  
7 
85  
±  
11 
88  
±  
12 
Glucose Average 
24 hours (mg/dl)+ 
101.7  
± 
 8.1 
99.3  
± 
 12.2 
99.9 
± 
9.3 
100.3  
±  
10.7 
103.9 
± 
6.5 
98.2 
± 
14.6 
Glucose Area 
Under the Curve 
24 hours (mg/dl) + 
140192  
± 
12885 
137240 
± 
17983 
136864 
± 
13005 
137874 
± 
17079 
143995 
± 
12585 
136515 
± 
20326 
VO2max (L/min)* 
2.21  
± 
 0.57 
2.56  
±  
0.75 
2.23  
±  
0.51 
2.54  
±  
0.65 
2.19  
± 
 0.65 
2.64  
±  
0.88 
VO2max 
(ml/kg/min)* 
21.35 
± 
4.37 
24.85 
± 
5.21 
22.37 
± 
3.85 
25.33 
± 
4.81 
20.35 
± 
4.86 
24.38 
± 
5.87 
+
 N = 15 for All, 7 HIT and 8 CONT. *Significant change from pre to post all 
subjects together. N = 8 for HIT Post VO2max data. 
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Figure 1: Maximal oxygen uptake (L/min) baseline, after 4 weeks of exercise, and after 8 
weeks of exercise. There was a significant time effect (P = 0.001), but no group x time 
interaction (P = 0.474). There were significant time effects between baseline and 4 weeks 
(P = 0.023), baseline and 8 weeks (P = 0.003), and 4 weeks and 8 weeks (P = 0.008). 
Individual data in lighter lines and mean data in bold lines. HIT group: circles, CONT 
group: squares.  
 
Continuous Glucose Monitoring 
 Due to missing data we removed the glucose results from three subjects in the 
HIT group therefore the whole group glucose results are on 6 subjects in the HIT group 
and 8 subjects in the CONT group. With these 13 subjects there were no statistical 
differences for glucose AUC or average 24 hour glucose between the group and time 
factors and the group x time factors (All P values > 0.40, See Table 3 and Figure 2). 
Subjects were split according to their baseline 24-hour average glucose value into two 
groups: > 100 mg/dl or < 100 mg/dl. There were 4 subjects from each intervention group 
(HIT and CONT) in the >100 mg/dl group. In the < 100 mg/dl group there were 2 
subjects from the HIT group and 4 from the CONT group. In the <100 mg/dl group there 
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were no significant changes from pre to post in average glucose (94.2 ± 4.7 to 103.6 ± 
12.4 mg/dl, P = 0.176) and glucose AUC (131336 ± 8814 to 144445 ± 15219, P = 0.203). 
In the >100 mg/dl group there were significant reductions pre to post in average glucose 
(107.8 ± 4.7 to 94.3 ± 10.8 mg/dl, P = 0.027) and glucose AUC (148684 ± 9777 to 
130310 ± 17068, P = 0.007). There were no statistical differences between the HIT and 
CONT groups or group x time interaction when the sample was split by average baseline 
glucose value (All P values > 0.30). There was a significant group x time interaction 
observed using the baseline glucose groups (AUC: P = 0.007, Average glucose: P = 
0.002) as shown in Figures 2-4. 
Figure 2: Average glucose values for all subjects (each 5 minute glucose reading) pre- 
(solid line) and post-intervention (dotted line). A) Continuous exercise group (CONT, N 
= 8), B) High-intensity Interval Training Group (HIT, N = 6). Error bars represent ± 1 
standard error. 
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Figure 3: Average glucose values (each 5 minute glucose reading) pre- (solid line) and 
post-intervention (dotted line) for A) Subjects with baseline average 24 hour glucose of < 
100 mg/dl (N = 8) and B) Subjects with baseline average 24 hour glucose of > 100 mg/dl 
(N=6). Intervention groups are together. Error bars represent ± 1 standard error. 
Significant reduction in average glucose in the >100 mg/dl group (P = 0.027), but not in 
the <100 mg/dl group (P = 0.176). 
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Figure 4: Glucose area under the curve (AUC) pre- and post-intervention for the subjects 
whose baseline average 24-hour glucose was greater than 100 mg/dl. There was a 
significant time effect (P = 0.027), but no group x time interaction (P = 0.388). Individual 
data in lighter lines and mean data in bold lines. HIT group: circles, CONT group: 
squares. 
 
 
Flow Mediated Dilation 
 There were no significant time, group or group x time effects for any 
measurements of blood flow, velocity, shear rate, peak diameter, or time to peak diameter 
when all three time points were considered. When all three time points were included the 
HIT group had a greater baseline diameter (HIT = 0.407 ± 0.067, CONT = 0.375 ± 0.060 
mm; P = 0.100) and had significantly larger peak diameter (HIT = 0.434 ± 0.066, CONT 
= 0.392 ± 0.058 mm; P = 0.027) and FMD response (HIT = 6.91 ± 4.03, CONT = 4.70 ± 
3.92%; P = 0.047) than did the CONT group. There were no significant time effects on 
any of the FMD variables. There was a significant group x time interaction in the FMD % 
(P = 0.043) as shown in table 4 and Figures 5-7.  
87 
When the baseline and 8 week data were considered only and the data was split 
by group, the CONT group had a significant increase in baseline diameter (0.367 to 0.386 
cm, P = 0.001), no change in peak diameter (0.388 to 0.396 cm, P = 0.301), and a 
significant decrease in FMD % (5.91 to 2.94%, P = 0.018). Conversely, the HIT group 
had no change in baseline diameter (0.404 to 0.409 cm, P = 0.542), a significant increase 
peak diameter (0.422 to 0.442 cm, P = 0.009), and a significant improvement in FMD % 
(4.82 to 8.62%, P = 0.045). Furthermore, with only the baseline and 8 week data included 
there was a significant group x time interaction for FMD % (P = 0.001). 
Since there were small non-significant differences in artery size between groups 
as well as differences in the pattern of diameter changes between groups it was 
appropriate to employ the allometric scaling technique described in the methods. 
Furthermore the slope of the ln adjusted change in baseline diameter (pre to post) 
between groups was only 0.89 (95% confidence interval = 0.81-0.97). The 
recommendations in the literature deem it necessary to employ allometric scaling if the 
slope is not close to 1.0 or if the 95% CI does not include 1 (Atkinson et al., 2013). 
Therefore the allometrically scaled FMD % between groups (results shown are after back 
transformation) was significantly higher in the HIT group compared to the CONT (See 
Figure 8).  
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Table 4: All outcomes from the brachial artery ultrasound measurements at 
baseline, 4 weeks, and 8 weeks. Values represent: Mean ± Standard deviation. 
  
  
Continuous HIT 
Baseline 4 Weeks 8 Weeks Baseline 4 Weeks 8 Weeks 
Diameter 
Baseline (cm) 
0.367 
± 
0.062 
0.374 
± 
0.063 
0.386 
± 
0.062 
0.404 
± 
0.07 
0.408 
± 
0.07 
0.409 
± 
0.07 
Diameter Peak 
(cm) 
0.388 
± 
0.065 
0.392 
± 
0.059 
0.396 
± 
0.056 
0.422 
± 
0.068 
0.436 
± 
0.067 
0.442 
± 
0.07 
Flow Mediated 
Dilation % 
5.91 
± 
4.32 
5.35 
± 
4.03 
2.84 
± 
3.09 
4.82 
± 
2.74 
7.29 
± 
2.94 
8.62* 
± 
5.33 
Average 
Velocity (cm/s) 
25.32 
± 
6.78 
24.44 
± 
11.37 
26.71 
± 
9.38 
26.31 
± 
9.41 
19.99 
± 
7.59 
20.09 
± 
6.26 
Average  Blood 
Flow (ml/min) 
2.86 
± 
1.16 
2.77 
± 
1.44 
3.14 
± 
1.41 
3.31 
± 
1.16 
2.78 
± 
1.3 
2.87 
± 
1.27 
Integral/min 
Flow (ml/min) 
171.53 
± 
69.61 
166 
± 
86.19 
188.41 
± 
84.84 
198.51 
± 
69.56 
166.6 
± 
78.4 
172.42 
± 
76.13 
Integral 
Anterograde 
Flow  (ml/min) 
171.6 
± 
69.53 
166.4 
± 
86.05 
188.68 
± 
84.65 
199.19 
± 
69.16 
166.8 
± 
78 
172.85 
± 
75.64 
Integral 
Retrograde 
Flow  (ml/min) 
-0.09 
± 
0.18 
-0.45 
± 
0.85 
-0.39 
± 
0.9 
-0.73 
± 
1.17 
-0.3 
± 
0.5 
-0.52 
± 
0.63 
Average Shear 
Rate (1/s) 
278.22 
± 
96.53 
267.05 
± 
144.01 
286.81 
± 
123.75 
278.13 
± 
151.03 
200.91 
± 
106.77 
198.17 
± 
89.26 
Integral/min 
Shear Rate 
16688.59 
±  
5791.75 
16019.53 
±  
8633.52 
17215.57 
±  
7425.56 
16684.72 
±  
9058.04 
12051.01 
±  
6389.11 
11891.1 
± 
5353.33 
Integral 
Anterograde 
Shear Rate 
16694 
± 
5781 
16052 
± 
8616 
17234 
± 
7401 
16749 
± 
9067 
12073 
± 
6386 
11920 
± 
5336 
Integral 
Retrograde 
Shear Rate 
-7.46 
± 
13.99 
-34.31 
± 
64.63 
-30.83 
± 
70.67 
-66.63 
± 
120.71 
-23.54 
± 
41.49 
-34.03 
± 
45.23 
Time to Peak 
(sec) 
64.78 
± 
13.19 
68.36 
± 
16.17 
68.98 
± 
20.37 
88.61 
± 
56.69 
68.71 
± 
18.46 
71.54 
± 
19.53 
* Significant group x time interaction, P < 0.05. 
89 
Figure 5: Brachial artery baseline (resting) diameter at baseline, 4 weeks, and 8 weeks in 
the A) Continuous exercise group and B) High-intensity exercise group. Individual 
subject and group values are shown. No significant changes over time. 
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Figure 6: Brachial artery peak (after cuff release) diameter at baseline, 4 weeks, and 8 
weeks in the A) Continuous exercise group and B) High-intensity exercise group. 
Individual subject and group values are shown. No significant changes over time, 
significant group difference (P = 0.027). 
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Figure 7: Percent increase in diameter from baseline to peak at baseline, 4 weeks, and 8 
weeks in the A) Continuous exercise group and B) High-intensity exercise group. 
Individual subject and group values are shown. No significant changes over time. 
Significant group difference (P = 0.047) and group x time interaction (P = 0.043).  
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Figure 8: Allometrically scaled flow mediated dilation at baseline, 4 weeks, and 8 weeks 
in the continuous exercise group (CONT, N = 8), high-intensity interval training group 
(HIT, N = 9).  *Significant group x time interaction (P = 0.006). 
 
Activity Monitoring 
 The acclerometer results are shown in Table 6. We obtained reliable data on 16 
subjects for baseline and 5th week testing and on only 9 subjects for the 8th week testing.  
There were no significant mean differences between the groups and time factors and the 
group x time interaction factor in any of the accelerometer outcomes. 
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Table 6: Outcomes from the accelerometers at baseline, 4 weeks, and 8 weeks. There 
were no significant differences between groups at baseline. Also using only the 
baseline and 5th week data there were no significant group, time, or group x time 
differences. Statistical analyses were not performed on the 8th week data due to small 
sample size. Values represent: Mean ± Standard deviation. 
Continuous HIT 
Baseline 
(N=7) 
5th 
Week 
(N=7) 
8th  
Week 
(N=4) 
Baseline 
(N=9) 
5th Week 
(N=9) 
8th  
Week 
(N=5) 
Sedentary 
Time 
(min/day) 
534.1  
± 
 93.6 
511.3  
± 
 47.7 
525.7  
± 
 76.1 
571.4  
± 
 69.8 
554.2  
± 
 111.8 
621.7  
± 
 61.5 
Light Activity 
Time 
(min/day) 
230.8  
± 
 61.1 
212.7  
± 
 56.1 
194.1  
± 
 35.4 
194.7  
± 
 62.7 
173.7  
± 
 61.2 
164.5  
± 
 76.3 
Lifestyle 
Activity 
(min/day) 
92.4  
±  
37.0 
81.6  
± 
 27.3 
64.4  
±  
18.8 
70.8  
±  
16.9 
72.7  
±  
24.1 
64.7  
±  
21.8 
Moderate 
Activity 
(min/day) 
24.8  
±  
9.2 
26.1  
±  
13.4 
20.5  
±  
10.2 
27.1  
±  
11.5 
23.8  
±  
11.9 
22  
±  
8.4 
Vigorous 
Activity 
(min/day) 
1.0 
±  
0.9 
0.2  
±  
0.3 
1.1  
±  
2.2 
0.6  
±  
0.8 
0.7  
±  
1.3 
1.4  
±  
1.8 
Vertical Axis 
(Counts/day) 
273863  
±  
72225 
251259  
±  
72299 
213979  
±  
65087 
237587  
±  
48744 
225546  
±  
67217 
209838  
±  
80668 
Vertical Axis 
(Counts/min) 
294  
±  
121 
296  
±  
128 
275  
±  
136 
276  
±  
114 
284 
±  
152 
238  
±  
110 
Steps/day 
6062  
±  
1713 
6536  
±  
1873 
5754  
±  
1248 
5819  
±  
1836 
5578  
±  
2059 
5519  
±  
2233 
 
Correlations 
 The change in FMD % was significantly correlated with the change in baseline 
artery diameter (r = -0.58, P = 0.015). The change in glucose AUC was significantly 
correlated with the change in body fat % (r = 0.59, P = 0.025). The change in baseline 
artery diameter was significantly correlated with the change weight (r = 0.53, P = 0.027) 
and lean mass (r = 0.62, P = 0.008). Abdominal circumference and sagittal diameter 
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measurements pre and post correlated moderately with VAT (r = 0.68, P <0.001 r = 0.52, 
P = 0.003, respectively), but the changes in each did not correlate well (sagittal diameter: 
r = 0.10, P = 0.712; waist circumference: r = 0.202, P = 0.416). The change in visceral fat 
was strongly associated with the change in fat mass (r = 0.80, P < 0.001) and weight (r = 
0.72, P = 0.002). The change in sedentary time between baseline and the 5th week was 
significantly related to physical activity enjoyment (r = -0.53, P = 0.036).  
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Chapter 5 
DISCUSSION 
 The current study compared the effects of high-intensity interval training to 
continuous exercise on endothelial function, glucose regulation, and visceral adipose 
tissue in obese individuals. The total exercise time in the HIT group including warm-up 
and cool-down times was only 72% of the time spent by the CONT group (11.6 vs. 16 
total hours). Despite the lower time commitment the interval training led to superior 
improvements in endothelial function in obese individuals. This study also showed that 
HIT and continuous exercise for eight weeks led to improvements in glucose regulation 
in the individuals whose average 24-hour glucose was above 100 mg/dl at baseline. 
Lastly, we showed no reduction in visceral adipose tissue measured by the iDXA even 
though there were significant reductions in waist circumference and sagittal diameter.  
Endothelial Function 
It is well known that exercise training in individuals with impaired vascular 
function leads to improvements in endothelial function (Green, 2009). Recent evidence 
suggests that HIT may lead to superior improvements in endothelial function (Ciolac et 
al., 2010; Molmen-Hansen et al., 2012; Schjerve et al., 2008; A. Tjonna et al., 2009; A. 
E. Tjonna et al., 2008; Wisloff et al., 2007) while other studies show similar 
improvements between continuous and interval training (Currie et al., 2013; T. Moholdt 
et al., 2011; Rakobowchuk et al., 2008). The only study conducted in obese individuals 
directly comparing HIT to CONT exercise training showed that 12 weeks of HIT led to 
superior improvements in FMD compared to CONT exercise (Schjerve et al., 2008). Our 
study used a similar sample with a mean BMI of ~36 kg/m2 and a slightly shorter training 
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duration (8 vs. 12 weeks), but the study by Schjerve and colleagues has several 
limitations. Firstly, Schjerve and colleagues measured artery diameter every 30 seconds 
using calipers instead of the recommended time-course measurement using advanced 
edge detection software (D. H. J. Thijssen et al., 2010). The use of calipers to measure 
artery diameter has been shown to produce large variability in FMD% (CV: 15.9%) 
compared to edge detection software (R. A. Harris et al., 2010). Furthermore, it is likely 
that the true peak diameter could have been missed using the 30 second windows of 
diameter measurement instead of the full time-course (Black et al., 2008). Conversely, we 
used the recommended time-course measurement of artery diameter using an externally 
validated (Woodman et al., 2001) advanced edge detection software in which we have 
shown our own high levels of reliability.  
Despite these methodological differences we found similar but not identical 
results. Using the un-scaled FMD % HIT led to an absolute increase of 3.8% while 
CONT exercise led to a decrease of 3.1%. Schjerve and colleagues (2008) showed an 
absolute increase in FMD % of 7.3 in the HIT and only 4.2 in the continuous group. 
Much of the drastic increase in FMD seen in the Schjerve et al study could have been 
driven by the fact that baseline diameter decreased in the HIIT group (0.402 to 0.391 cm), 
but did not change in the continuous group (0.400 to 0.401 cm). Interestingly, peak 
diameter increased in both groups by the same amount after the intervention (0.018 cm). 
Conversely, we observed divergent changes in artery diameter in response to the two 
exercise interventions. Peak diameter significantly increased in the HIT group, but not in 
the CONT group and baseline diameter significantly increased in the continuous group, 
but not in the HIT group. It has been recently shown that up to 64% of the variability in 
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FMD% can be explained by variation in baseline diameter (Atkinson & Batterham, 
2013). In our study the correlation between change in baseline diameter and change in 
FMD % was -0.61 indicating that 37% of the variance in FMD change was due to change 
in baseline diameter. Due to the divergent changes in artery diameter and the differences 
in baseline diameter at the onset of the study (HIT = 0.404 vs. CONT = 0.367, although 
not statistically different possibly impactful, see (Senn, 2006)) between groups the 
allometric scaling technique recently described (Atkinson et al., 2013) was appropriate in 
the current study. The allometrically scaled FMD values showed a similar FMD at 
baseline between groups followed by an absolute increase of 3.85% in the HIT group and 
an absolute decrease in the CONT group of 2.39% (Figure 19). The apparent reduction in 
FMD % in the CONT group while the HIT group increased using the un-scaled FMD is 
therefore partially explained by adjusting for baseline diameter. Therefore, the allometric 
scaling of FMD confirms our findings of a superior improvement in endothelial function 
in response to HIT and shows that CONT exercise may have led to structural remodeling 
and increased brachial artery diameter.  
The reason for the larger increase in brachial artery diameter and decrease in 
FMD in the CONT group compared to the HIT group is not apparent. Interestingly peak 
artery diameter increased at both 4 and 8 weeks in the CONT group, but the baseline 
diameter increased more, leading to a lower FMD. Other studies using 8 weeks of 
continuous cycling exercise at a similar intensity to our study showed no increase in 
FMD (Maiorana et al., 2001; D. Thijssen et al., 2007). Recent cross-sectional studies 
have shown that masters-level and professional athletes have much larger arteries 
(especially in the active limb for their sport) compared to age matched controls (Green et 
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al., 2013). Furthermore, it has recently been suggested that increases in artery diameter 
may be a function of time spent exercising (Spence, Carter, Naylor, & Green, 2013). 
Since the exercise intervention for the CONT group was 38% longer (in total exercise 
time) compared to the HIT intervention the differential changes in artery diameter may be 
partially explained by the longer total exercise time. It has also been proposed that in 
young normal weight individuals FMD may peak after 2 weeks of exercise training then 
start to decline as artery diameter increases and the stimulus for FMD (shear stress) 
declines (Tinken et al., 2008). Subsequently in our study we may have missed the peak in 
FMD if it occurred around 2 weeks in the CONT group. These structural adaptations 
have not been shown in an obese population, but could lead to improvements in vascular 
health despite decreasing FMD (Brown, 2003). Differing modulations and patterns of 
shear stress have been shown to cause differing effects on endothelial function and it is 
possible that HIT caused a different shear stress pattern compared to CONT exercise 
training (D. H. Thijssen, Dawson, Tinken, Cable, & Green, 2009; Tinken et al., 2009). 
One possibility is that the sustained duration of shear stress with continuous exercise led 
to more rapid vascular remodeling when compared to the transient nature of the shear 
stress with HIT in this population.  
 Most studies that have directly compared the effects of HIT to continuous 
exercise with FMD as an outcome have not reported baseline diameter (T. T. Moholdt et 
al., 2009; Molmen-Hansen et al., 2012; A. Tjonna et al., 2009; A. E. Tjonna et al., 2008; 
Wisloff et al., 2007). Furthermore, many of the direct comparison studies used calipers or 
non-time course analysis for measurement of artery diameter which may not be precise 
enough to detect small changes in artery diameter (T. T. Moholdt et al., 2009; Molmen-
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Hansen et al., 2012; Schjerve et al., 2008; A. Tjonna et al., 2009; A. E. Tjonna et al., 
2008; Wisloff et al., 2007). A recent study comparing 12 weeks of HIT to continuous 
exercise in CAD patients showed similar improvements in FMD % and a small non-
significant increase in brachial artery diameter in the continuous group (0.430 to 0.432 
mm) and with no change in the HIT group (0.452 to 0.452 mm) (Currie et al., 2013).  Our 
study is the first to show divergent changes in artery diameter between HIT and 
continuous exercise. More studies directly comparing HIT with continuous exercise 
utilizing larger samples, more frequent FMD measurement, and automated edge detection 
software are needed to confirm and expand on our findings of differential changes in 
artery diameter.  
The main proposed mechanism for increases in FMD in response to exercise 
training is the shear stress elicited by increased blood flow (G. K. Birk et al., 2012; 
Dimmeler et al., 1999; Green et al., 2004; Green, 2009; Lenk et al., 2011; Ribeiro et al., 
2010; Tinken et al., 2009). The increase in shear stress has been shown to lead to 
increased NO availability (Deljanin Ilic et al., 2009; Green et al., 2004) via increases in 
eNOS (Delp & Laughlin, 1997; Hambrecht et al., 2003; Sessa et al., 1994), increases in 
number and functional ability of endothelial progenitor cells (Dimmeler et al., 1999; 
Laufs et al., 2004; Lenk et al., 2011), increases in antioxidant capacity (Adams et al., 
2005; Edwards et al., 2004; Goto et al., 2007; Rush et al., 2000; Wisloff et al., 2007), and 
improvements in other CVD risk factors related to endothelial cell health (Ribeiro et al., 
2010).  
Reasons for the greater increase in FMD% and allometrically scaled FMD in the 
HIT group compared to the CONT group could be due to the larger levels of shear stress 
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induced by the higher exercise intensity with the interval training. Higher levels of shear 
stress theoretically lead to greater stimulus for the above mentioned effects of shear 
stress. This has been shown in humans and animals by greater increases in eNOS 
expression and phosphorylation, antioxidant capacity, NO availability, and greater 
decreases in oxidized LDL, in response to HIT compared to continuous exercise 
(Deljanin Ilic et al., 2009; Haram et al., 2009; Wisloff et al., 2007). Therefore, this study 
confirms previous findings that HIT leads to superior improvements in endothelial 
function when directly compared to continuous exercise and we extend the findings of 
Schjerve et al (2008)  showing that the effects hold true in an obese sample with more 
stringent FMD methodology.  
Interestingly, the change in FMD was inversely correlated with the change in 
abdominal circumference (r = -0.50, P = 0.041), but not with VAT (r = 0.004, P = 0.989). 
Cross-sectional studies have shown that abdominal circumference, waist to hip ratio, and 
VAT measured via CT scan are good predictors of endothelial function (Arcaro et al., 
1999; Brook, Bard, Rubenfire, Ridker, & Rajagopalan, 2001; Hashimoto et al., 1998). 
Furthermore, the change in VAT in response to a dietary weight loss program in healthy 
obese individuals has been shown to be inversely related the change in endothelial 
function (Park & Shim, 2005). We can speculate that the reductions in visceral fat could 
have led to reduced inflammation, oxidative stress, and increased NO availability, but we 
did not measure these markers (Ritchie & Connell, 2007). The reason for the iDXA 
measured VAT not correlating with FMD may be a methodological limitation of the 
iDXA which will be discussed in the VAT section. 
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Glucose regulation 
The ability of aerobic exercise to improve glucose regulation in individuals with 
impaired glucose tolerance as well as type 2 diabetes is well recognized (Boulé et al., 
2001; Snowling & Hopkins, 2006; Thomas et al., 2006). In the present study the time, 
group, or group x time effects for glucose regulation assessed via continuous glucose 
monitoring were not significant. The lack of effect may have been due to the fact that 
impaired fasting glucose was not an inclusion criteria for the study and many of the 
subjects started with normal glucose tolerance. Some studies have shown that subjects 
with normal glucose tolerance do not improve insulin sensitivity, glucose regulation, or 
insulin release in response to exercise interventions (Jenkins & Hagberg, 2011; 
Krotkiewski et al., 1985). To examine this hypothesis we divided our sample between 
individuals who started with average 24-hour glucose of greater than 100 mg/dl and those 
who started with average glucose below 100 mg/dl. The individuals who started with 
lower glucose levels did not improve glucose regulation but those who started with 
higher glucose levels decreased their average 24 hour glucose and glucose AUC values 
by 12.5% (See Figure 4). There were four subjects from each intervention group with 
baseline average glucose above 100 mg/dl, but no significant intervention group x time 
interactions were observed.  
The improvements in glucose regulation seen in the subjects with higher average 
glucose levels at the onset of the study could have been due to reductions in hepatic fat 
and improvements in liver insulin sensitivity leading to improved control of hepatic 
glucose release (Haram et al., 2009; Magkos, 2010; Shojaee-Moradie et al., 2007), 
improvements in pancreatic β-cell function via reductions in lipotoxicity and 
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improvements in insulin production (Bloem & Chang, 2008; Delghingaro-Augusto et al., 
2012; Malin & Kirwan, 2012), or improvements in peripheral insulin sensitivity via 
improved glucose uptake and insulin responsiveness in the peripheral tissues (DiPietro et 
al., 2006; Jenkins & Hagberg, 2011; Röckl et al., 2008). Interestingly, the change in body 
fat % was directly correlated with the change in glucose AUC (r = 0.59, P = 0.025). 
Reductions in body fat have been shown to be related to improvements in glucose 
regulation in some studies (Knowler et al., 2002; Pi-Sunyer et al., 2007), but 
improvements in glucose regulation can be realized without reductions in body fat 
(Gaesser, Angadi, & Sawyer, 2011). Since some of the variance in glucose regulation 
improvement can be accounted for by the change in body fat it is possible that the 
reductions in body fat were related to reductions in hepatic, pancreatic, and skeletal 
muscle fat accumulation leading to improved liver and peripheral insulin sensitivity as 
well as pancreatic β-cell function (Unger, 2002; Virtue & Vidal-Puig, 2010). 
Unfortunately without direct measurements of these lipid accumulation sites, insulin 
sensitivity and β-cell function we can only speculate.  
Conversely, other studies have shown significant improvements in insulin 
sensitivity (assessed via OGTT) in healthy normal glucose tolerant individuals of all ages 
(Babraj et al., 2009; Irving, Short, Nair, & Stump, 2011; Metcalfe et al., 2011; Short et 
al., 2003). The difference between our study and the results of other studies that have 
shown improvements in insulin sensitivity in healthy subjects is the fact that we did not 
measure insulin sensitivity. Insulin sensitivity is only one aspect of the determinants of 
glucose regulation. In young healthy individuals improvements in insulin sensitivity may 
not be detected via continuous glucose monitoring because the tissues were already 
103 
sensitive enough to keep glucose levels stable during normal dietary intake. The studies 
that showed improvements in insulin sensitivity employed the OGTT. The OGTT is 
unique in that individuals are given a large load of glucose which leads to larger levels of 
stress on the insulin-glucose system than normal dietary intake (Muniyappa, Lee, Chen, 
& Quon, 2008).  It may only be under conditions of high glucose intake that the glucose 
uptake system is stressed enough to notice the small changes that occur in individuals 
with NGT.  
Our results agree with most studies showing that improvements in glucose 
regulation are not dependent on exercise intensity (Bajpeyi et al., 2009; Houmard et al., 
2004; Larsen et al., 1997; Larsen et al., 1999; Slentz et al., 2009; Snowling & Hopkins, 
2006). The results from the STRRIDE trial showed that walking 12 miles/week  or 
jogging 20 miles/week were both better for improving insulin sensitivity than jogging 12 
miles/week suggesting total volume of exercise is the key factor (Houmard et al., 2004). 
The STRRIDE trial also showed that moderate exercise improved β-cell function to a 
greater extent than vigorous exercise (Slentz et al., 2009). Likewise multiple studies from 
Denmark show that light intensity exercise is just as effective in improving glucose 
regulation in diabetics as vigorous (Larsen et al., 1997; Larsen et al., 1999). Conversely, a 
few studies show superior benefits from vigorous or high-intensity exercise in improving 
insulin sensitivity (DiPietro et al., 2006; Haram et al., 2009), fasting insulin (E. Trapp et 
al., 2008), and markers of skeletal muscle mitochondrial function and glucose transport 
(Hood et al., 2011; Little et al., 2011). With the conflicting results in the literature, more 
large scale studies directly comparing HIT to continuous exercise need to be conducted.  
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The present study is the first HIT study to date utilizing continuous glucose 
monitoring to measure glucose regulation in non-diabetic obese subjects. Implementing 
time efficient exercise interventions that may improve glucose regulation in obese 
individuals who are prone to developing impaired glucose tolerance and T2D is a high 
priority. A recent cross-sectional study showed that abdominally obese men had 10% 
higher 24-hour average glucose levels, assessed via CGM, compared to non-abdominally 
obese men (Ma et al., 2011). The first exercise intervention using CGM in T2D found 
that 4 months of strength training improved glucose control, but endurance exercise did 
not. Those results must be taken with caution because there was no mention of dietary 
control during the CGM use (Cauza et al., 2005). A recent study using just six sessions of 
HIT over a two week period in type 2 diabetics showed significant reductions in glucose 
AUC and average glucose measured via CGM (Little et al., 2011). Another study showed 
that 7 days of exercise training in T2D improves glucose control and glycemic variability 
(Mikus et al., 2012).  Due to the fact that the CGMs in our study were worn 48-72 hours 
after the last exercise session we cannot rule out the possibility that the reduction in 
glucose AUC that we observed was due to the acute effects of exercise (Goodyear & 
Kahn, 1998).  Conversely, this timing was chosen specifically because most studies show 
that the acute effect of exercise is mostly gone by 48 hours and usually completely gone 
by 72 hours (Eriksson et al., 1997). Therefore the present study is the first to show 
improvements in glucose regulation assessed via CGM in obese subjects without 
diagnosed impaired glucose tolerance.  
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Visceral Adipose Tissue 
This was the first study to our knowledge attempting to use the iDXA to quantify 
changes in visceral adipose tissue in response to exercise training. Many studies have 
shown the effectiveness of aerobic exercise training in reducing VAT especially in obese 
subjects (Kay & Singh, 2006; Vissers et al., 2013). Conversely, after eight weeks of 
aerobic exercise training we observed no changes in VAT measured by the iDXA. Most 
studies evaluating VAT reductions with exercise use longer durations than the current 
study, but shorter term studies have shown reductions in VAT (Boudou, Sobngwi, 
Mauvais-Jarvis, Vexiau, & Gautier, 2003; Johnson et al., 2009; Mourier et al., 1997; 
Shojaee-Moradie et al., 2007). A study using only 4 weeks of cycling 3 days/week at a 
similar or lower intensity than our study in obese women led to a 12% reduction in VAT 
measured by MRI (Johnson et al., 2009). Another study using 3 days/week of exercise at 
60-85% of VO2max in overweight women showed a 17% reduction in VAT measured via 
CT scan (Shojaee-Moradie et al., 2007). Two studies using 8 weeks of aerobic exercise 
similar to our study showed VAT reductions of approximately 45% (Boudou et al., 2003; 
Mourier et al., 1997). It is not readily apparent why there was no reduction in VAT in our 
study.  
The iDXA has never been validated against CT or MRI for the ability to 
accurately quantify changes in VAT and it is possible that it is not sensitive enough to 
detect small changes. The iDXA has been shown to accurately track an increase in fat 
mass of 1 kg by placement of exogenous fatty tissue on humans (Warolin et al., 2012). In 
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that study the mean increase in fat mass assessed by the DXA was only 0.93 kg even 
though the mass of the added fat was 1.0 kg. There was no statistical difference between 
measured and added fat mass, but a mean difference of 0.07 kg while measuring 
exogenous fat could indicate larger variation while attempting to quantify deep visceral 
fat. Since the iDXA is a two-dimensional imaging system it relies on the width of the 
lateral compartments of abdominal subcutaneous fat to detect and extrapolate the width 
of the subcutaneous fat in the anterior region. This approach may lead to inaccurate 
estimates of VAT since individuals most likely have great variability in the level of 
subcutaneous fat in the lateral compartments compared to the anterior. Furthermore the 
total depth of the abdomen is assessed using the tissue attenuation levels measured by the 
iDXA which could also lead to error. In support of this argument our data show 
significant decreases in both abdominal circumference and sagittal diameter between pre- 
and post-intervention, but no change in visceral fat. Many studies have shown that 
abdominal circumference and sagittal diameter are significantly related to VAT (Pouliot 
et al., 1994; Rankinen, Kim, Perusse, Despres, & Bouchard, 1999; Van Der Kooy, 
Leenen, Seidell, Deurenberg, & Visser, 1993). Conversely, some studies have shown that 
changes in abdominal circumference and sagittal diameter are better predictors of 
changes in subcutaneous fat than VAT (Van Der Kooy et al., 1993). Interestingly, in our 
study abdominal circumference (r = 0.68, P <0.001) and sagittal diameter (r = 0.52, P = 
0.003) correlated moderately with VAT both pre and post, but the changes in each did not 
correlate well (Sagittal diameter: r = 0.10, P = 0.712; waist circumference: r = 0.202, P = 
0.416). These findings may imply that the iDXA is precise enough to quantify VAT at 
discrete time points, but not precise enough to quantify small changes in VAT which 
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could be less than 0.5 kg of fat. Furthermore, the change in VAT was highly correlated 
with the changes in fat mass (r = 0.80, P < 0.001) and weight (r = 0.72, P = 0.002). VAT 
reductions are commonly observed without weight loss (Boudou et al., 2003; Johnson et 
al., 2009; Shojaee-Moradie et al., 2007), but the high correlations between weight and fat 
mass change with iDXA measured VAT may shed light on the fact that the iDXA 
visceral fat measurements are more related to total mass. Alternatively, subjects in our 
study could have lost subcutaneous fat and not lost visceral fat to elicit the reduction in 
abdominal measurements. Without more direct measurement of visceral fat we cannot be 
certain. Studies validating the iDXA’s ability to accurately measure change in VAT by 
comparison to MRI or CT scan are needed.  
Some studies suggest that higher intensity exercise may lead to superior 
reductions in VAT (Coker et al., 2009; Irving et al., 2008), while others show no 
difference between moderate and vigorous intensities (Cho et al., 2011; Gutin et al., 
2002; Kay & Singh, 2006; Nicklas et al., 2009; Ohkawara et al., 2007; Slentz et al., 
2005). In our study both groups did vigorous intensity exercise and there were no 
reductions in VAT with either HIT or CONT exercise training. A recent study showed 
that 15 weeks of HIT led to superior reductions in trunk adiposity compared to steady-
state exercise training, but actual VAT was not measured (E. Trapp et al., 2008). The 
ability of HIT to reduce VAT is still largely unknown. More direct comparison studies 
using HIT versus continuous exercise and VAT measured with validated methods are 
needed.  
Maximal Oxygen Uptake 
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Many studies to date have compared HIT to continuous exercise for the 
improvement of maximal oxygen uptake. Some studies show that HIT elicits greater 
improvements in VO2max compared to continuous exercise (Rognmo, Hetland, Helgerud, 
Hoff, & Slørdahl, 2004; Schjerve et al., 2008; A. E. Tjonna et al., 2008; Wisloff et al., 
2007), but others have shown similar improvements (Ciolac et al., 2010; Currie et al., 
2013; Poole & Gaesser, 1985).  VO2max is widely known as the criterion measure of 
cardiorespiratory fitness and has been shown to be a strong predictor of all-cause and 
cardiovascular disease mortality rates across all BMI levels (Blair et al., 1989; Kavanagh 
et al., 2002; Wing et al., 2007). Furthermore, it has been shown that improvements in 
physical fitness significantly lower mortality risk independent of BMI and health status 
(Blair et al., 1995; Myers et al., 2002). The participants in our study had significant 
improvements in VO2max (15.8% overall). The approximate 3.5 ml/kg/min increase in 
VO2max seen in this study has been shown to reduce the risk of mortality by 11% (Myers 
et al., 2002). The HIT group improved by 21% and the CONT improved by 14%, but 
there was no difference between the groups. Many HIT studies in populations with low 
VO2max values have shown improvements of 30-50% (Schjerve et al., 2008; A. E. Tjonna 
et al., 2008; Wisloff et al., 2007). Our study may have been too short in duration to see 
improvements in VO2max to the extent that other studies observed. Although the 21% 
improvement in our HIT group in 8 weeks is similar or greater to what some other studies 
have reported (Ciolac et al., 2010; Currie et al., 2013; T. Moholdt et al., 2011; T. T. 
Moholdt et al., 2009; Molmen-Hansen et al., 2012). 
Resting Blood Pressure 
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We observed no reductions in resting blood pressure in response to the 
intervention. This is not surprising due to the fact that our subjects did not start out with 
hypertension. The baseline mean blood pressures were slightly in the pre-hypertensive 
range, but most subjects started with normal blood pressure. A meta-analysis showed that 
the expected reduction in systolic blood pressure in response to exercise training in 
normotensive individuals is only ~2-3 mmHg (Fagard, 2001).  Overall we observed a 1 
mmHg (not significant) reduction in resting systolic blood pressure which would require 
a much larger sample size to reach statistical significance.  
Body Composition and Anthropometrics 
This study led to no significant changes in body weight, body fat mass or lean 
mass. There was a significant reduction in body fat % measured by the DXA. The 
significant decrease in body fat % was caused by the 0.6 kg reduction in fat mass and the 
0.6 kg increase in lean mass neither of which were large enough to reach statistical 
significance on their own, but together they led to a small decrease in body fat %. We did 
not invoke a large enough calorie deficit to cause weight loss. The recommended amount 
of exercise to elicit weight loss is 200-300 min/week (Donnelly et al., 2009). Our 
participants only exercised for 90 to 120 minutes/week, therefore we did not expect 
weight loss to occur. This study is a good example of the health benefits of exercise 
(improved vascular function, structure, and glucose regulation) without weight loss. Even 
though all subjects were still considered obese at the conclusion of the study the 
improvements in health outcomes and VO2max show that they improved their 
cardiometabolic health without reductions in weight. 
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We did observe significant decreases in leg fat %, gynoid fat %, sagittal diameter 
and waist circumference with all subjects together. There were no differences between 
HIT and CONT for these parameters. The decreases in leg and gynoid fat % may be due 
to increased muscle mass in the legs and hips since the exercise was done completely 
with the legs. These changes in regional fat distributions are common in studies that 
involve cycling exercise (Wallman, Plant, Rakimov, & Maiorana, 2009). Some evidence 
suggests that HIT may be superior to continuous exercise for fat loss (Boutcher, 2010; E. 
Trapp et al., 2008). Evaluating methods of fat loss was not a goal of this study and our 
findings do not support this hypothesis.  
Activity Monitoring 
We did not observe any down regulation of physical activity in response to the 
exercise intervention in this group of subjects. Some studies have shown that individuals 
who start an exercise program tend to decrease their non-exercise activity thermogenesis 
throughout the rest of the day when they are not exercising (Colley, Hills, King, & Byrne, 
2010; M. I. Goran & Poehlman, 1992; Manthou, Gill, Wright, & Malkova, 2010). The 
evidence is still unclear as to whether or not exercise compensation occurs regularly, but 
it may be one of the many reasons individuals do not lose as much weight as expected in 
response to an exercise program (Gomersall, Rowlands, English, Maher, & Olds, 2013). 
The lack of down regulation in our study provides internal validity to our results because 
we know our subjects did not drastically change their activity patterns outside of the 
intervention over the course of the study. Interestingly we observed a moderate inverse 
correlation between the changes in sedentary time from pre-intervention to the 5th week 
of the intervention with physical activity enjoyment. Therefore, the less individuals 
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enjoyed the exercise in the study the more sedentary they became. This finding 
underscores the need for individualized exercise programs that allow subjects to choose 
their preferred mode of exercise if the desired outcome is sustained physical activity and 
decreased sedentary time.  
 
Strengths and Limitations 
The largest limitation of this study is the lack of dietary control during the course 
of the intervention. We cannot rule out the possibility that some of the changes we saw in 
our outcomes were related to dietary changes the subjects made over the course of the 
study. To control for this factor we continually reminded subjects of their commitment to 
maintain their current dietary habits. The lack of weight change is a good indicator that 
subjects did not start a hypocaloric diet over the course of the study. We chose to not use 
a sedentary control group and to use the continuous exercise as a standard of care control 
due to metabolic deterioration typically seen in sedentary control groups (Patel et al., 
2011). A strength of this study is the fact that compliance to the intervention was 100%. 
All subjects completed all 24 exercise sessions and each session was supervised by 
research technicians while heart rate was being monitored. Furthermore, we confirmed 
that subjects were not engaging in extra activity or down regulating other activity outside 
of the study by accelerometers. Therefore, it is likely that the changes we observed were 
due to our exercise intervention and not other changes the subjects made to their lifestyle. 
Conclusions 
In conclusion we showed that high-intensity interval training for eight weeks in 
obese individuals led to superior improvements in endothelial function when compared to 
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continuous vigorous exercise. Furthermore, by way of continuous glucose monitoring we 
showed that HIT and CONT exercise led to improvements in glucose regulation in 
individuals who had slightly impaired glucose regulation. Finally, visceral adipose tissue 
measured by the iDXA showed no changes. It is unclear whether this is due to 
methodological issues with the iDXA itself or if VAT did not change in our study. The 
strongest deterrent of participating in regular exercise is the time commitment required 
(Godin et al., 1994; Stutts, 2002; Trost et al., 2002). The time commitment for the 
subjects in the HIT group was 38% less, but these individuals realized superior or equal 
benefits in the health related outcomes. This study adds to the mounting evidence that 
high-intensity interval training is a time efficient strategy for improving health. We 
extend this evidence to show that obese adults can participate in HIT and improve their 
health without weight loss.   
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APPENDIX A  
STUDY FLOW DIAGRAM 
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APPENDIX B 
DIETARY INFORMATION: FOOD CONSUMED DURING CONTROLLED DIET 
PERIODS 
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 Kcal Fat g (Kcal) 
Carbohydrate 
g (Kcal) 
Protein 
g (Kcal) 
Breakfast     
Cinnamon 
Raisin Bagel 265 1 (9) 54 (216) 10 (40) 
Cream Cheese 
(2 T) 79 7 (63) 2 (8) 2 (8) 
Kern’s Nectar 
(12 oz) 164 0 41 (164) 0 
Lunch     
Lean Cuisine 300 8 (72) 39 (156) 18 (72) 
Sun Chips 218 10 (90) 29 (116) 3 (12) 
Dinner     
Subway: 
Sweet Onion 
Chicken 
Teriyaki 
Sandwich 
12”: 761 
6”: 380 
9 (81) 
4.5 (40.5) 
118 (472) 
59 (236) 
52 (208) 
26 (104) 
Doritos 253 13 (117) 30 (120) 4 (16) 
Powerade 
(12 oz) 76 0 19 (76) 0 
Snacks     
Nature Valley 
Sweet and 
Salty Peanut 
1: 86.5 
2:173 
1: 4.5 (40.5) 
2: 9 (81) 
1:  9.5 (38) 
2: 19 (76) 
1: 2 (8) 
2: 4 (16) 
     
Total Males 
% of Total 
Kcal 
2375.5 57 (513) 23% 
332 (1328) 
61% 
93 (372)  
16% 
Total 
Females 
% of Total 
Kcal 
1909 43.5 (391.5) 24% 
263.5 (1054) 
62% 
65 (260)  
14% 
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APPENDIX C 
STAMPED/APPROVED INFORMED CONSENT LETTER 
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APPENDIX D 
INSTITUIONAL REVIEW BOARD APPLICATION 
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APPENDIX E 
INSTITUTIONAL REVIEW BOARD APPROVAL 
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